 |
Abcam生化试剂65折促销 |
 |
现凡买任何生化试剂，即可享受65折优惠。 Abcam 提供一系列受体配体、离子通道调节剂、酶和信号传导工具。 所有这些产品均具有极高的纯度和非凡的品质。
|
货号 |
品名 |
描述 |
规格 |
价格 |
CAS 号 |
| AB118162 | NECA Fluorescent ligand (Red) | Fluorescent non-selective adenosine agonist | 50ug | 2831.00 | 774199-07-4 |
| AB118162 | NECA Fluorescent ligand (Red) | Fluorescent non-selective adenosine agonist | 100ug | 4607.00 | 774199-07-4 |
| AB118163 | XAC Fluorescent ligand (Red) | Fluorescent non-selective adenosine antagonist | 50ug | 2831.00 | 690267-56-5 |
| AB118163 | XAC Fluorescent ligand (Red) | Fluorescent non-selective adenosine antagonist | 100ug | 4607.00 | 690267-56-5 |
| AB118164 | XAC Fluorescent ligand | Fluorescent A3 antagonist | 50ug | 2831.00 | |
| AB118164 | XAC Fluorescent ligand | Fluorescent A3 antagonist | 100ug | 4607.00 | |
| AB118165 | Salbutamol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor agonist | 50ug | 2831.00 | |
| AB118165 | Salbutamol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor agonist | 100ug | 4607.00 | |
| AB118167 | Alprenolol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor antagonist | 50ug | 2831.00 | |
| AB118167 | Alprenolol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor antagonist | 100ug | 4607.00 | |
| AB118168 | Propranolol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor antagonist | 50ug | 2831.00 | |
| AB118168 | Propranolol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor antagonist | 100ug | 4607.00 | |
| AB118169 | (S)-Propranolol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor antagonist | 50ug | 2831.00 | |
| AB118169 | (S)-Propranolol Fluorescent ligand (Red) | Fluorescent beta2 adrenoceptor antagonist | 100ug | 4607.00 | |
| AB118170 | Pindolol Fluorescent ligand (Red) | Fluorescent beta2 antagonist | 50ug | 2831.00 | |
| AB118170 | Pindolol Fluorescent ligand (Red) | Fluorescent beta2 antagonist | 100ug | 4607.00 | |
| AB118171 | (S)-Carazolol Fluorescent ligand (Red) | Fluorescent beta3 adrenoceptor agonist | 50ug | 2831.00 | |
| AB118171 | (S)-Carazolol Fluorescent ligand (Red) | Fluorescent beta3 adrenoceptor agonist | 100ug | 4607.00 | |
| AB118172 | SKF83566 Fluorescent ligand (Red) | Fluorescent D1 antagonist | 50ug | 2831.00 | |
| AB118172 | SKF83566 Fluorescent ligand (Red) | Fluorescent D1 antagonist | 100ug | 4607.00 | |
| AB118173 | CGP-54626A Fluorescent ligand (Red) | Fluorescent GABAB antagonist | 50ug | 2831.00 | |
| AB118173 | CGP-54626A Fluorescent ligand (Red) | Fluorescent GABAB antagonist | 100ug | 4607.00 | |
| AB118174 | Mepyramine Fluorescent ligand (Red) | Fluorescent H1 antagonist | 50ug | 2831.00 | |
| AB118174 | Mepyramine Fluorescent ligand (Red) | Fluorescent H1 antagonist | 100ug | 4607.00 | |
| AB118175 | Aminopotentidine Fluorescent ligand (Red) | Fluorescent H2 antagonist | 50ug | 2831.00 | |
| AB118175 | Aminopotentidine Fluorescent ligand (Red) | Fluorescent H2 antagonist | 100ug | 4607.00 | |
| AB118176 | Pirenzepine Fluorescent ligand (Red) | Fluorescent M3 antagonist | 50ug | 2831.00 | |
| AB118176 | Pirenzepine Fluorescent ligand (Red) | Fluorescent M3 antagonist | 100ug | 4607.00 | |
| AB118177 | NAN-190 Fluorescent ligand (Red) | Fluorescent 5-HT1A antagonist | 50ug | 2831.00 | |
| AB118177 | NAN-190 Fluorescent ligand (Red) | Fluorescent 5-HT1A antagonist | 100ug | 4607.00 | |
| AB118649 | Clobenpropit Fluorescent ligand (Red) | Fluorescent H3 antagonist | 50ug | 2831.00 | |
| AB118649 | Clobenpropit Fluorescent ligand (Red) | Fluorescent H3 antagonist | 100ug | 4607.00 | |
| AB118650 | ZM549865 Fluorescent ligand (Red) | Fluorescent 5-HT1B antagonist | 50ug | 2831.00 | |
| AB118650 | ZM549865 Fluorescent ligand (Red) | Fluorescent 5-HT1B antagonist | 100ug | 4607.00 | |
| AB120001 | DL-AP4 | Broad spectrum glutamate antagonist | 1g | 4884.00 | 20263-07-4 |
| AB120001 | DL-AP4 | Broad spectrum glutamate antagonist | 100mg | 500.00 | 20263-07-4 |
| AB120002 | L-AP4 | Selective group III mGlu agonist | 1mg | 611.00 | 23052-81-5 |
| AB120002 | L-AP4 | Selective group III mGlu agonist | 10mg | 1610.00 | 23052-81-5 |
| AB120002 | L-AP4 | Selective group III mGlu agonist | 50mg | 7160.00 | 23052-81-5 |
| AB120003 | D-AP5 | NMDA glutamate site antagonist | 1mg | 500.00 | 79055-68-8 |
| AB120003 | D-AP5 | NMDA glutamate site antagonist | 10mg | 1388.00 | 79055-68-8 |
| AB120003 | D-AP5 | NMDA glutamate site antagonist | 50mg | 6161.00 | 79055-68-8 |
| AB120003 | D-AP5 | NMDA glutamate site antagonist | 100mg | 8381.00 | 79055-68-8 |
| AB120004 | DL-AP5 | NMDA glutamate site antagonist | 10mg | 611.00 | 76326-31-3 |
| AB120004 | DL-AP5 | NMDA glutamate site antagonist | 50mg | 2775.00 | 76326-31-3 |
| AB120005 | (S)-AMPA | AMPA agonist | 5mg | 1277.00 | 83643-88-3 |
| AB120005 | (S)-AMPA | AMPA agonist | 10mg | 2109.00 | 83643-88-3 |
| AB120005 | (S)-AMPA | AMPA agonist | 50mg | 9158.00 | 83643-88-3 |
| AB120006 | (S)-3,4-DCPG (UBP1109) | mGlu8a agonist | 10mg | 1776.00 | 201730-11-2 |
| AB120006 | (S)-3,4-DCPG (UBP1109) | mGlu8a agonist | 50mg | 7770.00 | 201730-11-2 |
| AB120007 | (S)-3,5-DHPG | Selective group I mGlu agonist | 5mg | 1388.00 | 162870-29-3 |
| AB120007 | (S)-3,5-DHPG | Selective group I mGlu agonist | 10mg | 2387.00 | 162870-29-3 |
| AB120008 | MPEP hydrochloride | Potent, selective mGlu5 antagonist | 10mg | 1110.00 | 96206-92-7 |
| AB120008 | MPEP hydrochloride | Potent, selective mGlu5 antagonist | 50mg | 4884.00 | 96206-92-7 |
| AB120009 | PPADS | P2 purinergic receptor antagonist. | 10mg | 611.00 | 149017-66-3 |
| AB120009 | PPADS | P2 purinergic receptor antagonist. | 50mg | 2498.00 | 149017-66-3 |
| AB120009 | PPADS | P2 purinergic receptor antagonist. | 250mg | 9990.00 | 149017-66-3 |
| AB120010 | Quisqualic acid | Group I mGlu agonist. AMPA agonist. | 5mg | 999.00 | 52809-07-1 |
| AB120010 | Quisqualic acid | Group I mGlu agonist. AMPA agonist. | 10mg | 1887.00 | 52809-07-1 |
| AB120010 | Quisqualic acid | Group I mGlu agonist. AMPA agonist. | 50mg | 8159.00 | 52809-07-1 |
| AB120011 | AMN082 dihydrochloride | mGlu7 agonist | 10mg | 999.00 | 97075-46-2 |
| AB120011 | AMN082 dihydrochloride | mGlu7 agonist | 50mg | 4496.00 | 97075-46-2 |
| AB120012 | CGP 37157 | Na+-Ca2+ exchange inhibitor | 10mg | 1610.00 | 75450-34-9 |
| AB120012 | CGP 37157 | Na+-Ca2+ exchange inhibitor | 50mg | 6993.00 | 75450-34-9 |
| AB120013 | (±)-Anatoxin A fumarate | Potent nicotinic agonist | 1mg | 1610.00 | 64285-06-9 |
| AB120014 | SNAP | NO donor | 10mg | 611.00 | 67776-06-1 |
| AB120014 | SNAP | NO donor | 50mg | 1998.00 | 67776-06-1 |
| AB120015 | YM298198 hydrochloride | Potent, selective mGlu1 antagonist | 10mg | 1776.00 | 748758-45-4 |
| AB120015 | YM298198 hydrochloride | Potent, selective mGlu1 antagonist | 50mg | 7770.00 | 748758-45-4 |
| AB120016 | Desmethyl YM298198 hydrochloride | Analogue of mGlu1 antagonist YM298198 | 10mg | 1776.00 | 299901-57-8 |
| AB120016 | Desmethyl YM298198 hydrochloride | Analogue of mGlu1 antagonist YM298198 | 50mg | 7770.00 | 299901-57-8 |
| AB120017 | CNQX | AMPA / kainate antagonist | 10mg | 1277.00 | 115066-14-3 |
| AB120017 | CNQX | AMPA / kainate antagonist | 25mg | 2997.00 | 115066-14-3 |
| AB120017 | CNQX | AMPA / kainate antagonist | 50mg | 5273.00 | 115066-14-3 |
| AB120018 | DNQX | AMPA / kainate antagonist | 10mg | 500.00 | 2379-57-9 |
| AB120018 | DNQX | AMPA / kainate antagonist | 50mg | 1499.00 | 2379-57-9 |
| AB120019 | Clozapine | Atypical antipsychotic | 50mg | 1110.00 | 5786-21-0 |
| AB120019 | Clozapine | Atypical antipsychotic | 500mg | 5883.00 | 5786-21-0 |
| AB120020 | (R,S)-3,5-DHPG | Group I mGlu receptor agonist | 1mg | 500.00 | 19641-83-9 |
| AB120020 | (R,S)-3,5-DHPG | Group I mGlu receptor agonist | 10mg | 1277.00 | 19641-83-9 |
| AB120020 | (R,S)-3,5-DHPG | Group I mGlu receptor agonist | 50mg | 5661.00 | 19641-83-9 |
| AB120021 | Thioperamide maleate | Potent, selective H3 antagonist | 10mg | 999.00 | 106243-16-7 |
| AB120021 | Thioperamide maleate | Potent, selective H3 antagonist | 50mg | 4496.00 | 106243-16-7 |
| AB120022 | ODQ | Selective, potent inhibitor of NO-sensitive guanylyl cyclase | 10mg | 888.00 | 41443-28-1 |
| AB120022 | ODQ | Selective, potent inhibitor of NO-sensitive guanylyl cyclase | 50mg | 3608.00 | 41443-28-1 |
| AB120023 | 5,7-Dichlorokynurenic acid | NMDA receptor glycine site antagonist | 10mg | 777.00 | 131123-76-7 |
| AB120023 | 5,7-Dichlorokynurenic acid | NMDA receptor glycine site antagonist | 50mg | 2997.00 | 131123-76-7 |
| AB120023 | 5,7-Dichlorokynurenic acid | NMDA receptor glycine site antagonist | 100mg | 5772.00 | 131123-76-7 |
| AB120024 | 7-Chlorokynurenic acid | NMDA receptor glycine site antagonist | 10mg | 777.00 | 18000-24-3 |
| AB120024 | 7-Chlorokynurenic acid | NMDA receptor glycine site antagonist | 50mg | 2997.00 | 18000-24-3 |
| AB120025 | Capsazepine | VR1 antagonist | 10mg | 1499.00 | 138977-28-3 |
| AB120025 | Capsazepine | VR1 antagonist | 50mg | 5994.00 | 138977-28-3 |
| AB120026 | N-Desmethyl clozapine (Normethylclozapine) | Clozapine metabolite. M1 agonist. D2/D3 agonist. | 10mg | 1499.00 | 6104-71-8 |
| AB120026 | N-Desmethyl clozapine (Normethylclozapine) | Clozapine metabolite. M1 agonist. D2/D3 agonist. | 50mg | 5994.00 | 6104-71-8 |
| AB120027 | (+)-MK 801 maleate (Dizocilpine) | Non-competitive NMDA antagonist | 10mg | 777.00 | 77086-22-7 |
| AB120027 | (+)-MK 801 maleate (Dizocilpine) | Non-competitive NMDA antagonist | 50mg | 2775.00 | 77086-22-7 |
| AB120028 | (-)-MK 801 maleate | Non competitive NMDA antagonist; less active enantiomer | 10mg | 777.00 | 77086-19-2 |
| AB120028 | (-)-MK 801 maleate | Non competitive NMDA antagonist; less active enantiomer | 50mg | 2498.00 | 77086-19-2 |
| AB120029 | (R,S)-Rolipram | Selective PDE4 inhibitor | 10mg | 999.00 | 61413-54-5 |
| AB120029 | (R,S)-Rolipram | Selective PDE4 inhibitor | 50mg | 3996.00 | 61413-54-5 |
| AB120030 | (S)-(+)-Rolipram | PDE4 inhibitor; less active enantiomer | 10mg | 1887.00 | 85416-73-5 |
| AB120030 | (S)-(+)-Rolipram | PDE4 inhibitor; less active enantiomer | 50mg | 8159.00 | 85416-73-5 |
| AB120031 | (R)-(-)-Rolipram | Selective PDE4 inhibitor | 10mg | 1887.00 | 85416-75-7 |
| AB120031 | (R)-(-)-Rolipram | Selective PDE4 inhibitor | 50mg | 8159.00 | 85416-75-7 |
| AB120032 | (+/-)-Thalidomide | Immunomodulator and anticancer agent | 100mg | 611.00 | 50-35-1 |
| AB120033 | (R,S)-MCPG | Group I /II metabotropic glutamate antagonist | 10mg | 1388.00 | 146669-29-6 |
| AB120033 | (R,S)-MCPG | Group I /II metabotropic glutamate antagonist | 50mg | 5661.00 | 146669-29-6 |
| AB120034 | Fenobam | Selective, potent, orally active mGlu5 antagonist | 10mg | 1110.00 | 57653-26-6 |
| AB120034 | Fenobam | Selective, potent, orally active mGlu5 antagonist | 50mg | 4995.00 | 57653-26-6 |
| AB120035 | MTEP hydrochloride | Potent, selective mGlu5 antagonist | 10mg | 1388.00 | 1186195-60-7 |
| AB120035 | MTEP hydrochloride | Potent, selective mGlu5 antagonist | 50mg | 5883.00 | 1186195-60-7 |
| AB120036 | (S)-5-Fluorowillardiine | Potent, selective AMPA agonist | 10mg | 1610.00 | 140187-23-1 |
| AB120036 | (S)-5-Fluorowillardiine | Potent, selective AMPA agonist | 50mg | 6993.00 | 140187-23-1 |
| AB120037 | 2-Chloroadenosine (CADO) | Adenosine agonist | 10mg | 389.00 | 146-77-0 |
| AB120037 | 2-Chloroadenosine (CADO) | Adenosine agonist | 50mg | 999.00 | 146-77-0 |
| AB120037 | 2-Chloroadenosine (CADO) | Adenosine agonist | 250mg | 4107.00 | 146-77-0 |
| AB120038 | 2,3 cis-Piperidine dicarboxylic acid (cis PDA) | Ionotropic receptor antagonist | 50mg | 999.00 | 46026-75-9 |
| AB120038 | 2,3 cis-Piperidine dicarboxylic acid (cis PDA) | Ionotropic receptor antagonist | 250mg | 3996.00 | 46026-75-9 |
| AB120039 | (R,S)-CHPG | Selective mGlu5 agonist | 10mg | 888.00 | 170846-74-9 |
| AB120039 | (R,S)-CHPG | Selective mGlu5 agonist | 50mg | 3996.00 | 170846-74-9 |
| AB120040 | (S)-Willardiine | AMPA / kainate receptor agonist | 10mg | 1277.00 | 21416-43-3 |
| AB120040 | (S)-Willardiine | AMPA / kainate receptor agonist | 50mg | 5661.00 | 21416-43-3 |
| AB120041 | Ibotenic acid | Excitotoxic agonist | 1mg | 1110.00 | 2552-55-8 |
| AB120041 | Ibotenic acid | Excitotoxic agonist | 5mg | 2609.00 | 2552-55-8 |
| AB120041 | Ibotenic acid | Excitotoxic agonist | 25mg | 9990.00 | 2552-55-8 |
| AB120042 | SR95531 (Gabazine) | GABAA antagonist | 10mg | 1110.00 | 104104-50-9 |
| AB120042 | SR95531 (Gabazine) | GABAA antagonist | 50mg | 4607.00 | 104104-50-9 |
| AB120043 | PHCCC | Selective allosteric potentiator at mGlu4. Also group I antagonist. | 10mg | 1388.00 | |
| AB120043 | PHCCC | Selective allosteric potentiator at mGlu4. Also group I antagonist. | 50mg | 5883.00 | |
| AB120044 | CNQX disodium salt | AMPA / kainate antagonist (water soluble) | 1mg | 500.00 | 115066-14-3 |
| AB120044 | CNQX disodium salt | AMPA / kainate antagonist (water soluble) | 10mg | 1110.00 | 115066-14-3 |
| AB120044 | CNQX disodium salt | AMPA / kainate antagonist (water soluble) | 50mg | 5106.00 | 115066-14-3 |
| AB120045 | NBQX | AMPA / kainate antagonist | 10mg | 1776.00 | 118876-58-7 |
| AB120045 | NBQX | AMPA / kainate antagonist | 50mg | 7770.00 | 118876-58-7 |
| AB120046 | NBQX disodium salt | AMPA / kainate antagonist; water soluble | 1mg | 888.00 | 118876-58-7 |
| AB120046 | NBQX disodium salt | AMPA / kainate antagonist; water soluble | 10mg | 2109.00 | 118876-58-7 |
| AB120046 | NBQX disodium salt | AMPA / kainate antagonist; water soluble | 50mg | 8991.00 | 118876-58-7 |
| AB120047 | cis-PPDA | GluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist | 10mg | 1499.00 | |
| AB120047 | cis-PPDA | GluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist | 50mg | 5994.00 | |
| AB120048 | D-Serine | Endogenous NMDA receptor co-agonist | 1g | 278.00 | 312-84-5 |
| AB120048 | D-Serine | Endogenous NMDA receptor co-agonist | 5g | 888.00 | 312-84-5 |
| AB120049 | L-Glutamate | Excitatory neurotransmitter | 1g | 389.00 | 56-86-0 |
| AB120049 | L-Glutamate | Excitatory neurotransmitter | 2500mg | 777.00 | 56-86-0 |
| AB120050 | Glycine | Inhibitory neurotransmitter | 1g | 500.00 | 56-40-6 |
| AB120050 | Glycine | Inhibitory neurotransmitter | 100mg | 278.00 | 56-40-6 |
| AB120051 | Spermine | Endogenous polyamine | 1g | 611.00 | 71-44-3 |
| AB120051 | Spermine | Endogenous polyamine | 100mg | 389.00 | 71-44-3 |
| AB120052 | NMDA | Excitotoxic amino acid | 50mg | 777.00 | 6384-92-5 |
| AB120052 | NMDA | Excitotoxic amino acid | 100mg | 999.00 | 6384-92-5 |
| AB120052 | NMDA | Excitotoxic amino acid | 500mg | 3386.00 | 6384-92-5 |
| AB120054 | Tetrodotoxin | Na+ channel blocker | 1mg | 1776.00 | 4368-28-9 |
| AB120055 | Tetrodotoxin citrate | Na+ channel blocker; water-soluble | 1mg | 1887.00 | 18660-81-6 |
| AB120056 | Staurosporine | Staurosporine | 100ug | 1277.00 | 62996-74-1 |
| AB120056 | Staurosporine | Staurosporine | 500ug | 4995.00 | 62996-74-1 |
| AB120057 | Spermidine hydrochloride | Endogenous polyamine. nNOS inhibitor | 100mg | 611.00 | 334-50-9 |
| AB120058 | Forskolin | Adenylyl cyclase activator | 10mg | 1388.00 | 66575-29-9 |
| AB120058 | Forskolin | Adenylyl cyclase activator | 50mg | 5772.00 | 66575-29-9 |
| AB120058 | Forskolin | Adenylyl cyclase activator | 100mg | 9990.00 | 66575-29-9 |
| AB120059 | (S)-MCPG | Group I / II mGlu antagonist | 10mg | 2276.00 | 150145-89-4 |
| AB120059 | (S)-MCPG | Group I / II mGlu antagonist | 50mg | 9657.00 | 150145-89-4 |
| AB120060 | CPCCOEt | Selective, non-competitive mGlu1 antagonist | 10mg | 1277.00 | 179067-99-3 |
| AB120060 | CPCCOEt | Selective, non-competitive mGlu1 antagonist | 50mg | 5661.00 | 179067-99-3 |
| AB120061 | Cyclothiazide | AMPA receptor desensitisation inhibitor | 10mg | 777.00 | 2259-96-3 |
| AB120061 | Cyclothiazide | AMPA receptor desensitisation inhibitor | 50mg | 3386.00 | 2259-96-3 |
| AB120062 | (S)-5-Chlorowillardiine | AMPA / kainate agonist | 10mg | 1499.00 | |
| AB120062 | (S)-5-Chlorowillardiine | AMPA / kainate agonist | 50mg | 6771.00 | |
| AB120063 | (S)-5-Nitrowillardiine | AMPA / kainate agonist | 10mg | 1499.00 | |
| AB120063 | (S)-5-Nitrowillardiine | AMPA / kainate agonist | 50mg | 6771.00 | |
| AB120064 | Kynurenic acid | Endogenous ionotropic / nicotinic antagonist | 1g | 389.00 | 492-27-3 |
| AB120065 | SP600125 | JNK inhibitor | 10mg | 888.00 | 129-56-6 |
| AB120065 | SP600125 | JNK inhibitor | 50mg | 3386.00 | 129-56-6 |
| AB120066 | Dihydrokainic acid | EAAT2 inhibitor | 1mg | 611.00 | 52497-36-6 |
| AB120066 | Dihydrokainic acid | EAAT2 inhibitor | 10mg | 1499.00 | 52497-36-6 |
| AB120066 | Dihydrokainic acid | EAAT2 inhibitor | 50mg | 6771.00 | 52497-36-6 |
| AB120067 | LY 367385 | mGlu1a antagonist | 10mg | 1610.00 | 198419-91-9 |
| AB120067 | LY 367385 | mGlu1a antagonist | 50mg | 6993.00 | 198419-91-9 |
| AB120068 | Mirtazapine | Antidepressant. alpha2, 5HT2, 5HT3 antagonist | 10mg | 999.00 | 61337-67-5 |
| AB120068 | Mirtazapine | Antidepressant. alpha2, 5HT2, 5HT3 antagonist | 50mg | 4107.00 | 61337-67-5 |
| AB120069 | Paroxetine hydrochloride | 5HT uptake inhibitor | 10mg | 999.00 | 110429-35-1 |
| AB120069 | Paroxetine hydrochloride | 5HT uptake inhibitor | 50mg | 4496.00 | 110429-35-1 |
| AB120070 | Nociceptin (Orphanin FQ) | ORL1 agonist | 1mg | 1277.00 | 170713-75-4 |
| AB120070 | Nociceptin (Orphanin FQ) | ORL1 agonist | 5mg | 4107.00 | 170713-75-4 |
| AB120071 | Obestatin | Endogenous peptide involved in feeding | 1mg | 611.00 | 869705-22-6 |
| AB120072 | Methyllycaconitine citrate (MLA) | alpha7-nicotinic receptor antagonist | 5mg | 777.00 | 21019-30-7 |
| AB120072 | Methyllycaconitine citrate (MLA) | alpha7-nicotinic receptor antagonist | 25mg | 2775.00 | 21019-30-7 |
| AB120073 | (+)-Tubocurarine | ACh receptor antagonist | 10mg | 278.00 | 6989-98-6 |
| AB120073 | (+)-Tubocurarine | ACh receptor antagonist | 50mg | 500.00 | 6989-98-6 |
| AB120074 | Naloxone hydrochloride | Opioid antagonist | 100mg | 777.00 | 357-08-4 |
| AB120074 | Naloxone hydrochloride | Opioid antagonist | 250mg | 1277.00 | 357-08-4 |
| AB120075 | Naltrexone hydrochloride | Opioid antagonist | 100mg | 611.00 | 16676-29-2 |
| AB120075 | Naltrexone hydrochloride | Opioid antagonist | 250mg | 1388.00 | 16676-29-2 |
| AB120076 | Zopiclone | Benzodiazepine agonist | 10mg | 1388.00 | 43200-80-2 |
| AB120076 | Zopiclone | Benzodiazepine agonist | 50mg | 5772.00 | 43200-80-2 |
| AB120077 | Fluoxetine hydrochloride | 5HT reuptake inhibitor | 10mg | 777.00 | 56296-78-7 |
| AB120077 | Fluoxetine hydrochloride | 5HT reuptake inhibitor | 50mg | 2997.00 | 56296-78-7 |
| AB120078 | nor-Binaltorphimine (nor-BNI) | Potent and selective kappa opioid receptor antagonist | 10mg | 1277.00 | 105618-26-6 |
| AB120078 | nor-Binaltorphimine (nor-BNI) | Potent and selective kappa opioid receptor antagonist | 50mg | 5994.00 | 105618-26-6 |
| AB120079 | Phospho-Glycogen Synthase Peptide-2 | GSK substrate | 1mg | 4385.00 | |
| AB120079 | Phospho-Glycogen Synthase Peptide-2 | GSK substrate | 500ug | 2387.00 | |
| AB120080 | Haloperidol | D2 antagonist | 100mg | 611.00 | 52-86-8 |
| AB120081 | FCCP | Mitochondrial oxidative phosphorylation inhibitor | 10mg | 999.00 | 370-86-5 |
| AB120081 | FCCP | Mitochondrial oxidative phosphorylation inhibitor | 50mg | 3608.00 | 370-86-5 |
| AB120082 | SL 327 | MEK inhibitor | 1mg | 777.00 | 305350-87-2 |
| AB120082 | SL 327 | MEK inhibitor | 10mg | 1776.00 | 305350-87-2 |
| AB120082 | SL 327 | MEK inhibitor | 25mg | 4274.00 | 305350-87-2 |
| AB120083 | Ryanodine | Ca2+ release modulator | 1mg | 1610.00 | 15662-33-6 |
| AB120084 | Salvinorin A (Divinorin A) | Potent kappa agonist | 1mg | 1388.00 | 83729-01-5 |
| AB120084 | Salvinorin A (Divinorin A) | Potent kappa agonist | 5mg | 4995.00 | 83729-01-5 |
| AB120087 | Anandamide (ethanol solution) | Endogenous cannabinoid | 5mg | 611.00 | 94421-68-8 |
| AB120087 | Anandamide (ethanol solution) | Endogenous cannabinoid | 25mg | 2775.00 | 94421-68-8 |
| AB120088 | AM251 | CB1 receptor antagonist / inverse agonist | 1mg | 500.00 | 183232-66-8 |
| AB120088 | AM251 | CB1 receptor antagonist / inverse agonist | 10mg | 1388.00 | 183232-66-8 |
| AB120088 | AM251 | CB1 receptor antagonist / inverse agonist | 50mg | 6161.00 | 183232-66-8 |
| AB120089 | XE-991 dihydrochloride | Potent, selective KCNQ channel blocker; blocks M current | 10mg | 1110.00 | 122955-42-4 |
| AB120089 | XE-991 dihydrochloride | Potent, selective KCNQ channel blocker; blocks M current | 50mg | 4607.00 | 122955-42-4 |
| AB120093 | Cycloheximide | Protein synthesis inhibitor | 1g | 611.00 | 66-81-9 |
| AB120093 | Cycloheximide | Protein synthesis inhibitor | 100mg | 389.00 | 66-81-9 |
| AB120094 | Muscimol | Potent, selective GABAA agonist | 1mg | 611.00 | 2763-96-4 |
| AB120094 | Muscimol | Potent, selective GABAA agonist | 5mg | 888.00 | 2763-96-4 |
| AB120094 | Muscimol | Potent, selective GABAA agonist | 10mg | 1388.00 | 2763-96-4 |
| AB120094 | Muscimol | Potent, selective GABAA agonist | 50mg | 5772.00 | 2763-96-4 |
| AB120095 | AM404 | Anandamide transport inhibitor | 10mg | 777.00 | 198022-70-7 |
| AB120095 | AM404 | Anandamide transport inhibitor | 50 mg |
2997.00 | 198022-70-7 |
| AB120096 | ACEA (ethanol solution) | Potent, selective CB1 agonist | 5mg | 611.00 | 220556-69-4 |
| AB120096 | ACEA (ethanol solution) | Potent, selective CB1 agonist | 25mg | 2775.00 | 220556-69-4 |
| AB120097 | ACPA (Arachidonylcyclopropylamide) | CB1 agonist | 10mg | 888.00 | 229021-64-1 |
| AB120097 | ACPA (Arachidonylcyclopropylamide) | CB1 agonist | 50mg | 3608.00 | 229021-64-1 |
| AB120098 | 2-Arachidonylglycerol (acetonitrile solution) | Endogenous cannabinoid agonist | 5mg | 2387.00 | 53847-30-6 |
| AB120098 | 2-Arachidonylglycerol (acetonitrile solution) | Endogenous cannabinoid agonist | 25mg | 6993.00 | 53847-30-6 |
| AB120099 | NADA (N-Arachidonyldopamine) | Endogenous CB1 / TRPV1 agonist | 5mg | 888.00 | 199875-69-9 |
| AB120099 | NADA (N-Arachidonyldopamine) | Endogenous CB1 / TRPV1 agonist | 25mg | 3996.00 | 199875-69-9 |
| AB120100 | Kainic acid | Prototypic kainate receptor agonist. | 1mg | 500.00 | 58002-62-3 |
| AB120100 | Kainic acid | Prototypic kainate receptor agonist. | 10mg | 1388.00 | 58002-62-3 |
| AB120100 | Kainic acid | Prototypic kainate receptor agonist. | 50mg | 6161.00 | 58002-62-3 |
| AB120101 | U 93631 | GABAA antagonist | 10mg | 1499.00 | 152273-12-6 |
| AB120101 | U 93631 | GABAA antagonist | 50mg | 6383.00 | 152273-12-6 |
| AB120102 | ZD7288 | Sino-atrial node function modulator | 10mg | 1277.00 | 133059-99-1 |
| AB120102 | ZD7288 | Sino-atrial node function modulator | 50mg | 5384.00 | 133059-99-1 |
| AB120107 | (+)-Bicuculline | GABAA antagonist | 50mg | 1776.00 | 485-49-4 |
| AB120108 | (-)-Bicuculline methiodide | GABAA antagonist | 10mg | 611.00 | 55950-07-7 |
| AB120108 | (-)-Bicuculline methiodide | GABAA antagonist | 50mg | 2387.00 | 55950-07-7 |
| AB120109 | (-)-Bicuculline methobromide | GABAA antagonist | 10mg | 999.00 | 73604-30-5 |
| AB120109 | (-)-Bicuculline methobromide | GABAA antagonist | 50mg | 4496.00 | 73604-30-5 |
| AB120110 | (-)-Bicuculline methochloride | GABAA antagonist | 10mg | 999.00 | 53552-05-9 |
| AB120110 | (-)-Bicuculline methochloride | GABAA antagonist | 50mg | 4274.00 | 53552-05-9 |
| AB120111 | Ifenprodil | GluN2B (formerly NR2B)-preferring NMDA antagonist | 10mg | 611.00 | 23210-58-4 |
| AB120111 | Ifenprodil | GluN2B (formerly NR2B)-preferring NMDA antagonist | 50mg | 2886.00 | 23210-58-4 |
| AB120112 | Genistein | Protein tyrosine kinase inhibitor. Anticancer agent. | 10mg | 389.00 | 446-72-0 |
| AB120112 | Genistein | Protein tyrosine kinase inhibitor. Anticancer agent. | 50mg | 1499.00 | 446-72-0 |
| AB120112 | Genistein | Protein tyrosine kinase inhibitor. Anticancer agent. | 100mg | 2775.00 | 446-72-0 |
| AB120114 | Cyclosporin A | PP2B inhibitor | 25mg | 500.00 | 59865-13-3 |
| AB120114 | Cyclosporin A | PP2B inhibitor | 100mg | 999.00 | 59865-13-3 |
| AB120114 | Cyclosporin A | PP2B inhibitor | 500mg | 2609.00 | 59865-13-3 |
| AB120115 | Camptothecin | DNA topoisomerase inhibitor | 50mg | 611.00 | 7689-03-4 |
| AB120115 | Camptothecin | DNA topoisomerase inhibitor | 250mg | 1998.00 | 7689-03-4 |
| AB120116 | Ionomycin Ca2+ Salt | Ca2+ ionophore | 1mg | 1277.00 | 56092-82-1 |
| AB120116 | Ionomycin Ca2+ Salt | Ca2+ ionophore | 5mg | 4995.00 | 56092-82-1 |
| AB120117 | QX-314 bromide (N-Ethyllidocaine bromide) | Na+ channel blocker | 50mg | 611.00 | 21306-56-9 |
| AB120117 | QX-314 bromide (N-Ethyllidocaine bromide) | Na+ channel blocker | 100mg | 999.00 | 21306-56-9 |
| AB120118 | QX-314 chloride (N-Ethyllidocaine chloride) | Na+ channel blocker | 50mg | 1110.00 | 21306-56-9 |
| AB120119 | N-Methyllidocaine iodide (QX-372 iodide) | Anti-arrthymic | 10mg | 1110.00 | 29199-61-9 |
| AB120119 | N-Methyllidocaine iodide (QX-372 iodide) | Anti-arrthymic | 50mg | 4496.00 | 29199-61-9 |
| AB120121 | D-Cycloserine | NMDA glycine site agonist | 50mg | 389.00 | 68-41-7 |
| AB120121 | D-Cycloserine | NMDA glycine site agonist | 250mg | 1499.00 | 68-41-7 |
| AB120122 | 4-Aminopyridine (4-AP) | K+ channel blocker | 100mg | 500.00 | 504-24-5 |
| AB120123 | Aminoguanidine hydrochloride | NOS inhibitor | 100mg | 777.00 | 1937-19-5 |
| AB120124 | 2-APB | Ca2+ release modulator | 100mg | 500.00 | 524-95-8 |
| AB120125 | Granisetron | 5HT3 antagonist | 50mg | 2276.00 | 107007-99-8 |
| AB120125 | Granisetron | 5HT3 antagonist | 250mg | 6882.00 | 107007-99-8 |
| AB120126 | QX-222 | Na+ channel blocker | 10mg | 500.00 | 21236-55-5 |
| AB120126 | QX-222 | Na+ channel blocker | 50mg | 1998.00 | 21236-55-5 |
| AB120127 | CGP 37849 | Competitive NMDA antagonist | 10mg | 1776.00 | 127910-31-0 |
| AB120127 | CGP 37849 | Competitive NMDA antagonist | 50mg | 7770.00 | 127910-31-0 |
| AB120128 | CGP 39551 | Competitive NMDA antagonist | 10mg | 1499.00 | 127910-32-1 |
| AB120128 | CGP 39551 | Competitive NMDA antagonist | 50mg | 6383.00 | 127910-32-1 |
| AB120129 | Y-27632 dihydrochloride | Selective Rho kinase inhibitor | 1mg | 888.00 | 146986-50-7 |
| AB120129 | Y-27632 dihydrochloride | Selective Rho kinase inhibitor | 10mg | 2276.00 | 146986-50-7 |
| AB120129 | Y-27632 dihydrochloride | Selective Rho kinase inhibitor | 50mg | 9657.00 | 146986-50-7 |
| AB120130 | (R,S)-AMPA | AMPA agonist | 10mg | 1776.00 | 74341-63-2 |
| AB120130 | (R,S)-AMPA | AMPA agonist | 50mg | 7493.00 | 74341-63-2 |
| AB120131 | ICI 182,780 | Estrogen receptor antagonist | 10mg | 1776.00 | 129453-61-8 |
| AB120131 | ICI 182,780 | Estrogen receptor antagonist | 50mg | 7770.00 | 129453-61-8 |
| AB120132 | Ketanserin tartrate | Selective 5HT2 antagonist. | 50mg | 888.00 | 83846-83-7 |
| AB120132 | Ketanserin tartrate | Selective 5HT2 antagonist. | 250mg | 3996.00 | 83846-83-7 |
| AB120133 | Citalopram | 5HT reuptake inhibitor | 25mg | 1110.00 | 59729-32-7 |
| AB120133 | Citalopram | 5HT reuptake inhibitor | 100mg | 4274.00 | 59729-32-7 |
| AB120134 | Ondansetron | Selective 5HT3 antagonist. | 10mg | 888.00 | 99614-02-5 |
| AB120134 | Ondansetron | Selective 5HT3 antagonist. | 50mg | 3608.00 | 99614-02-5 |
| AB120135 | Nifedipine | L-type Ca2+ channel blocker | 1g | 500.00 | 21829-25-4 |
| AB120135 | Nifedipine | L-type Ca2+ channel blocker | 250mg | 389.00 | 21829-25-4 |
| AB120136 | Nomega-Nitro-L-arginine Methyl Ester hydrochloride (L-NAME) | NOS inhibitor | 100mg | 611.00 | 51298-62-5 |
| AB120137 | NG-Monomethyl-L-arginine, monoacetate salt (L-NMMA) | NOS inhibitor | 10mg | 500.00 | 53308-83-1 |
| AB120137 | NG-Monomethyl-L-arginine, monoacetate salt (L-NMMA) | NOS inhibitor | 50mg | 2109.00 | 53308-83-1 |
| AB120138 | Nimodipine | L-type Ca2+ channel blocker | 100mg | 611.00 | 66085-59-4 |
| AB120138 | Nimodipine | L-type Ca2+ channel blocker | 500mg | 2609.00 | 66085-59-4 |
| AB120139 | Nitrendipine | L-type Ca2+ channel blocker | 100mg | 1887.00 | 39562-70-4 |
| AB120139 | Nitrendipine | L-type Ca2+ channel blocker | 500mg | 7493.00 | 39562-70-4 |
| AB120140 | Verapamil hydrochloride | L-type Ca2+ channel blocker | 1g | 777.00 | 152-11-4 |
| AB120141 | Apigenin | Anticancer agent | 10mg | 389.00 | 520-36-5 |
| AB120141 | Apigenin | Anticancer agent | 50mg | 1499.00 | 520-36-5 |
| AB120142 | Isradipine | L-type Ca2+ channel blocker | 10mg | 999.00 | 75695-93-1 |
| AB120142 | Isradipine | L-type Ca2+ channel blocker | 50mg | 4496.00 | 75695-93-1 |
| AB120143 | Paclitaxel | Anticancer agent | 10mg | 1110.00 | 33069-62-4 |
| AB120143 | Paclitaxel | Anticancer agent | 50mg | 4107.00 | 33069-62-4 |
| AB120144 | 4-DAMP | Muscarinic receptor antagonist | 25mg | 500.00 | 1952-15-4 |
| AB120144 | 4-DAMP | Muscarinic receptor antagonist | 100mg | 1776.00 | 1952-15-4 |
| AB120145 | Nicotinic acid (Niacin) | Antidyslipidemic agent | 10g | 278.00 | 59-67-6 |
| AB120147 | Herkinorin | Non-internalising μ opioid agonist | 1mg | 1499.00 | |
| AB120148 | Wortmannin | PI3-kinase inhibitor | 1mg | 777.00 | 19545-26-7 |
| AB120148 | Wortmannin | PI3-kinase inhibitor | 5mg | 2498.00 | 19545-26-7 |
| AB120149 | (R,S)-Baclofen | GABAB agonist | 1g | 611.00 | 1134-47-0 |
| AB120150 | 6,7-ADTN hydrobromide | Dopamine agonist | 10mg | 611.00 | 13575-86-5 |
| AB120150 | 6,7-ADTN hydrobromide | Dopamine agonist | 50mg | 2775.00 | 13575-86-5 |
| AB120151 | AQ-RA 741 | M2 antagonist | 10mg | 1388.00 | 123548-16-3 |
| AB120151 | AQ-RA 741 | M2 antagonist | 50mg | 5772.00 | 123548-16-3 |
| AB120152 | AF-DX 116 (Otenzepad) | M2 antagonist | 10mg | 1499.00 | 102394-31-0 |
| AB120152 | AF-DX 116 (Otenzepad) | M2 antagonist | 50mg | 5994.00 | 102394-31-0 |
| AB120153 | Pirenzepine dihydrochloride | M1 antagonist | 100mg | 611.00 | 28797-61-7 |
| AB120153 | Pirenzepine dihydrochloride | M1 antagonist | 500mg | 1610.00 | 28797-61-7 |
| AB120156 | Tropisetron hydrochloride | 5-HT3 antagonist | 10mg | 1277.00 | 105826-92-4 |
| AB120156 | Tropisetron hydrochloride | 5-HT3 antagonist | 50mg | 5384.00 | 105826-92-4 |
| AB120157 | Reboxetine mesylate | Noradrenaline reuptake inhibitor | 10mg | 1388.00 | 71620-89-8 |
| AB120157 | Reboxetine mesylate | Noradrenaline reuptake inhibitor | 50mg | 6161.00 | 71620-89-8 |
| AB120158 | E-4031 dihydrochloride | HERG K+ channel blocker | 10mg | 1610.00 | 113559-13-0 |
| AB120158 | E-4031 dihydrochloride | HERG K+ channel blocker | 50mg | 6993.00 | 113559-13-0 |
| AB120159 | (R)-CPP | Potent NMDA antagonist | 10mg | 2997.00 | 126453-07-4 |
| AB120159 | (R)-CPP | Potent NMDA antagonist | 50mg | 13376.00 | 126453-07-4 |
| AB120160 | (R,S)-CPP | Potent NMDA antagonist | 10mg | 1499.00 | 100828-16-8 |
| AB120160 | (R,S)-CPP | Potent NMDA antagonist | 50mg | 6383.00 | 100828-16-8 |
| AB120161 | PPT | Subtype selective ERalpha agonist | 10mg | 1610.00 | 263717-53-9 |
| AB120161 | PPT | Subtype selective ERalpha agonist | 50mg | 6272.00 | 263717-53-9 |
| AB120162 | SB 203580 | p38 MAP kinase inhibitor | 1mg | 888.00 | 152121-47-6 |
| AB120162 | SB 203580 | p38 MAP kinase inhibitor | 10mg | 1887.00 | 152121-47-6 |
| AB120162 | SB 203580 | p38 MAP kinase inhibitor | 50mg | 8381.00 | 152121-47-6 |
| AB120163 | SB431542 | ALK inhibitor | 1mg | 999.00 | 301836-41-9 |
| AB120163 | SB431542 | ALK inhibitor | 5mg | 1277.00 | 301836-41-9 |
| AB120163 | SB431542 | ALK inhibitor | 10mg | 2276.00 | 301836-41-9 |
| AB120165 | 1400W | Selective iNOS inhibitor | 10mg | 1110.00 | 180001-34-7 |
| AB120165 | 1400W | Selective iNOS inhibitor | 50mg | 4884.00 | 180001-34-7 |
| AB120166 | DPN | Potent, selective ERbeta agonist | 10mg | 1110.00 | 1428-67-7 |
| AB120166 | DPN | Potent, selective ERbeta agonist | 50mg | 5106.00 | 1428-67-7 |
| AB120167 | CGP 35348 | GABAB antagonist, brain penetrant | 10mg | 1610.00 | 123690-79-9 |
| AB120167 | CGP 35348 | GABAB antagonist, brain penetrant | 50mg | 6993.00 | 123690-79-9 |
| AB120168 | UBP310 | GluK1 and GluK3 selective antagonist | 10mg | 1499.00 | |
| AB120168 | UBP310 | GluK1 and GluK3 selective antagonist | 50mg | 5994.00 | |
| AB120169 | DNQX disodium salt | AMPA / kainate antagonist (water soluble) | 10mg | 611.00 | |
| AB120169 | DNQX disodium salt | AMPA / kainate antagonist (water soluble) | 50mg | 2498.00 | |
| AB120170 | Substance P | Sensory neuropeptide | 1mg | 500.00 | 33507-63-0 |
| AB120170 | Substance P | Sensory neuropeptide | 5mg | 1277.00 | 33507-63-0 |
| AB120171 | Neuropeptide Y 13-36 (porcine) | NPY Y2 agonist | 1mg | 2276.00 | 113662-54-7 |
| AB120171 | Neuropeptide Y 13-36 (porcine) | NPY Y2 agonist | 5mg | 8880.00 | 113662-54-7 |
| AB120172 | Galanin (1-16) (porcine, rat) | N-terminal galanin fragment | 1mg | 1887.00 | |
| AB120172 | Galanin (1-16) (porcine, rat) | N-terminal galanin fragment | 500ug | 999.00 | |
| AB120173 | LY 354740 | Group II mGlu agonist. Systemically active. | 10mg | 1776.00 | 176199-48-7 |
| AB120173 | LY 354740 | Group II mGlu agonist. Systemically active. | 50mg | 7770.00 | 176199-48-7 |
| AB120174 | Neuropeptide S (mouse) | NPS receptor agonist | 1mg | 3996.00 | |
| AB120175 | (Arg-8)-Vasopressin (AVP) | Vasopressin receptor agonist | 1mg | 611.00 | 113-79-1 |
| AB120175 | (Arg-8)-Vasopressin (AVP) | Vasopressin receptor agonist | 5mg | 2387.00 | 113-79-1 |
| AB120176 | SLIGRL-NH2 | PAR2 agonist peptide | 1mg | 777.00 | 171436-38-7 |
| AB120177 | TFLLR-NH2 | PAR1 agonist peptide | 1mg | 2387.00 | 197794-83-5 |
| AB120178 | BAM (8-22) (Bovine Adrenal Medulla 8-22) | SNSR agonist | 1mg | 2997.00 | 412961-36-5 |
| AB120179 | AY-NH2 | PAR4 agonist peptide | 1mg | 2387.00 | 352017-71-1 |
| AB120179 | AY-NH2 | PAR4 agonist peptide | 5mg | 5661.00 | 352017-71-1 |
| AB120180 | VIP (Vasoactive Intestinal Peptide) (6-28) | VPAC antagonist | 1mg | 2276.00 | 69698-54-0 |
| AB120181 | Kisspeptin-13 (4-13) (human) (KiSS-1 (112-121)) | AXOR12 agonist | 1mg | 2775.00 | 374675-21-5 |
| AB120182 | SAMS peptide | AMP-activated protein kinase substrate | 1mg | 1388.00 | 125911-68-4 |
| AB120182 | SAMS peptide | AMP-activated protein kinase substrate | 5mg | 5495.00 | 125911-68-4 |
| AB120183 | Angiotensin II (human) | Vasoconstrictor peptide | 5mg | 611.00 | 68521-88-0 |
| AB120183 | Angiotensin II (human) | Vasoconstrictor peptide | 25mg | 1499.00 | 68521-88-0 |
| AB120184 | Luteinizing Hormone Releasing Hormone (LHRH) | Reproductive hormone | 5mg | 1776.00 | 33515-09-2 |
| AB120184 | Luteinizing Hormone Releasing Hormone (LHRH) | Reproductive hormone | 25mg | 4995.00 | 33515-09-2 |
| AB120185 | Neurokinin A | Tachykinin peptide | 5mg | 1887.00 | 86933-74-6 |
| AB120185 | Neurokinin A | Tachykinin peptide | 25mg | 7493.00 | 86933-74-6 |
| AB120186 | Oxytocin | Reproductive hormone | 5mg | 888.00 | 50-56-6 |
| AB120186 | Oxytocin | Reproductive hormone | 25mg | 3386.00 | 50-56-6 |
| AB120188 | Locustatachykinin I | Insect tachykinin-related peptide | 1mg | 1610.00 | 126985-97-5 |
| AB120189 | alpha-MSH (alpha-Melanocyte-stimulating hormone) | Endogenous melanocortin receptor agonist | 1mg | 611.00 | 581-05-5 |
| AB120189 | alpha-MSH (alpha-Melanocyte-stimulating hormone) | Endogenous melanocortin receptor agonist | 5mg | 1998.00 | 581-05-5 |
| AB120190 | NKH 477 (Colforsin daropate) | Water-soluble analogue of forskolin ab120058, an adenylyl cyclase activator | 10mg | 1776.00 | 138605-00-2 |
| AB120190 | NKH 477 (Colforsin daropate) | Water-soluble analogue of forskolin ab120058, an adenylyl cyclase activator | 50mg | 7770.00 | 138605-00-2 |
| AB120191 | JNJ 10191584 maleate (VUF 6002) | Selective H4 antagonist | 10mg | 888.00 | 869497-75-6 |
| AB120191 | JNJ 10191584 maleate (VUF 6002) | Selective H4 antagonist | 50mg | 5384.00 | 869497-75-6 |
| AB120192 | Dynasore | Cell permeable dynamin inhibitor | 10mg | 1110.00 | 304448-55-3 |
| AB120192 | Dynasore | Cell permeable dynamin inhibitor | 50mg | 4884.00 | 304448-55-3 |
| AB120193 | UBP141 | GluN2D (formerly NR2D) antagonist, with some subunit selectivity | 10mg | 1277.00 | 344768-30-5 |
| AB120194 | UBP304 | Potent, selective GluK1 (fomerly GLUK5) receptor antagonist | 10mg | 1887.00 | |
| AB120195 | UBP308 | Inactive isomer of the GluK1 (fomerly GLUK5) receptor antagonist UBP304 | 10mg | 1887.00 | |
| AB120196 | LY 379268 | Group II mGlu agonist. Systemically active. | 10mg | 3275.00 | 191471-52-0 |
| AB120196 | LY 379268 | Group II mGlu agonist. Systemically active. | 50mg | 14652.00 | 191471-52-0 |
| AB120199 | LY 341495 | Potent, selective group II antagonist. Group III antagonist at higher concentrations. | 1mg | 888.00 | 201943-63-7 |
| AB120199 | LY 341495 | Potent, selective group II antagonist. Group III antagonist at higher concentrations. | 10mg | 2276.00 | 201943-63-7 |
| AB120199 | LY 341495 | Potent, selective group II antagonist. Group III antagonist at higher concentrations. | 50mg | 9657.00 | 201943-63-7 |
| AB120201 | LY 456236 | mGlu1 non competitive antagonist | 10mg | 1110.00 | 338738-57-1 |
| AB120201 | LY 456236 | mGlu1 non competitive antagonist | 50mg | 4884.00 | 338738-57-1 |
| AB120202 | SB 216763 | Potent selective GSK-3 inhibitor | 1mg | 611.00 | 280744-09-4 |
| AB120202 | SB 216763 | Potent selective GSK-3 inhibitor | 10mg | 1610.00 | 280744-09-4 |
| AB120202 | SB 216763 | Potent selective GSK-3 inhibitor | 50mg | 6660.00 | 280744-09-4 |
| AB120204 | Oxytocin (free acid) | Reproductive hormone | 5mg | 888.00 | 24346-32-5 |
| AB120205 | alpha-MSH (free acid) | Endogenous melanocortin receptor agonist | 5mg | 2276.00 | 10466-28-1 |
| AB120208 | Neuropeptide Y (NPY) (human, rat) | Endogenous neuropeptide | 1mg | 5883.00 | 90880-35-6 |
| AB120208 | Neuropeptide Y (NPY) (human, rat) | Endogenous neuropeptide | 500ug | 2997.00 | 90880-35-6 |
| AB120209 | CCK Octapeptide sulfated | C-terminal ocatapeptide of CCK | 1mg | 1388.00 | 25126-32-3 |
| AB120210 | omega-Agatoxin IVA | Ca2+ channel blocker (P and Q type) | 10ug | 1776.00 | 145017-83-0 |
| AB120210 | omega-Agatoxin IVA | Ca2+ channel blocker (P and Q type) | 100ug | 5994.00 | 145017-83-0 |
| AB120211 | omega-Conotoxin MVIIC | Ca2+ channel blocker (P and Q-type) | 100ug | 1998.00 | 147794-23-8 |
| AB120211 | omega-Conotoxin MVIIC | Ca2+ channel blocker (P and Q-type) | 500ug | 7770.00 | 147794-23-8 |
| AB120212 | Orexin A (bovine, human, mouse, rat) | Neuropeptide involved in feeding and sleep | 1mg | 6272.00 | 205640-90-0 |
| AB120212 | Orexin A (bovine, human, mouse, rat) | Neuropeptide involved in feeding and sleep | 100ug | 1499.00 | 205640-90-0 |
| AB120212 | Orexin A (bovine, human, mouse, rat) | Neuropeptide involved in feeding and sleep | 500ug | 3774.00 | 205640-90-0 |
| AB120214 | Exendin-4 (Exenatide) | Potent GLP-1 receptor agonist | 1mg | 3608.00 | 141758-74-9 |
| AB120214 | Exendin-4 (Exenatide) | Potent GLP-1 receptor agonist | 500ug | 1998.00 | 141758-74-9 |
| AB120215 | omega-Conotoxin GVIA | Ca2+ channel blocker (N type) | 1mg | 6882.00 | 106375-28-4 |
| AB120215 | omega-Conotoxin GVIA | Ca2+ channel blocker (N type) | 500ug | 3885.00 | 106375-28-4 |
| AB120218 | ZM 241385 | Potent, selective A2A antagonist | 10mg | 1388.00 | 139180-30-6 |
| AB120218 | ZM 241385 | Potent, selective A2A antagonist | 50mg | 5883.00 | 139180-30-6 |
| AB120219 | Gabapentin | alpha2delta ligand | 10mg | 888.00 | 60142-96-3 |
| AB120219 | Gabapentin | alpha2delta ligand | 50mg | 3608.00 | 60142-96-3 |
| AB120220 | D4476 | CK1 inhibitor | 10mg | 1776.00 | 301836-43-1 |
| AB120220 | D4476 | CK1 inhibitor | 50mg | 7770.00 | 301836-43-1 |
| AB120221 | (R,S)-CHPG sodium salt | mGlu5 agonist; water soluble | 10mg | 1110.00 | |
| AB120221 | (R,S)-CHPG sodium salt | mGlu5 agonist; water soluble | 50mg | 4496.00 | |
| AB120222 | (S)-5-Iodowillardiine | GluK1 kainate agonist | 10mg | 1499.00 | 140187-25-3 |
| AB120222 | (S)-5-Iodowillardiine | GluK1 kainate agonist | 50mg | 6771.00 | 140187-25-3 |
| AB120223 | FK506 (Tacrolimus) | Immunosuppressant | 10mg | 1110.00 | 104987-11-3 |
| AB120223 | FK506 (Tacrolimus) | Immunosuppressant | 50mg | 4995.00 | 104987-11-3 |
| AB120224 | Rapamycin | Immunosuppressant | 1mg | 2276.00 | 53123-88-9 |
| AB120224 | Rapamycin | Immunosuppressant | 5mg | 7493.00 | 53123-88-9 |
| AB120225 | Harmine | Potent and selective inhibitor of DYRK1A | 100mg | 500.00 | 442-51-3 |
| AB120226 | Vincristine sulfate salt | Microtubule inhibitor | 5mg | 611.00 | 2068-78-2 |
| AB120226 | Vincristine sulfate salt | Microtubule inhibitor | 25mg | 2498.00 | 2068-78-2 |
| AB120227 | Etoposide | Topoisomerase II inhibitor | 25mg | 500.00 | 33419-42-0 |
| AB120227 | Etoposide | Topoisomerase II inhibitor | 100mg | 1110.00 | 33419-42-0 |
| AB120230 | Ghrelin (human) | Endogenous GHS agonist | 1mg | 3608.00 | 258279-04-8 |
| AB120231 | Ghrelin (rat) | Endogenous GHS agonist | 1mg | 3996.00 | 258338-12-4 |
| AB120232 | (R)-CPPene (SDZ EAA 494) | Potent competitive NMDA antagonist | 10mg | 3386.00 | 117414-74-1 |
| AB120233 | 7-Nitroindazole | NOS inhibitor | 50mg | 611.00 | 2942-42-9 |
| AB120234 | PD 98059 | MEK1 inhibitor | 1mg | 500.00 | 167869-21-8 |
| AB120234 | PD 98059 | MEK1 inhibitor | 10mg | 1277.00 | 167869-21-8 |
| AB120234 | PD 98059 | MEK1 inhibitor | 50mg | 5384.00 | 167869-21-8 |
| AB120235 | SB 203580 hydrochloride | p38 MAP kinase inhibitor; water soluble | 10mg | 2276.00 | 869185-85-3 |
| AB120236 | Rasagiline mesylate | MAO-B inhibitor | 10mg | 500.00 | 161735-79-1 |
| AB120236 | Rasagiline mesylate | MAO-B inhibitor | 50mg | 1277.00 | 161735-79-1 |
| AB120237 | Tiagabine hydrochloride | Selective GAT-1 inhibitor | 10mg | 999.00 | 115103-54-3 |
| AB120237 | Tiagabine hydrochloride | Selective GAT-1 inhibitor | 50mg | 3996.00 | 115103-54-3 |
| AB120238 | Prazosin hydrochloride | alpha-adrenoceptor antagonist. Melatonin antagonist. | 50mg | 500.00 | 19237-84-4 |
| AB120238 | Prazosin hydrochloride | alpha-adrenoceptor antagonist. Melatonin antagonist. | 250mg | 2109.00 | 19237-84-4 |
| AB120239 | Yohimbine hydrochloride | Selective alpha2-adrenoceptor antagonist | 1g | 389.00 | 65-19-0 |
| AB120239 | Yohimbine hydrochloride | Selective alpha2-adrenoceptor antagonist | 5g | 1388.00 | 65-19-0 |
| AB120240 | Caffeine | PDE inhibitor. Adenosine antagonist | 1g | 278.00 | 58-08-2 |
| AB120240 | Caffeine | PDE inhibitor. Adenosine antagonist | 5g | 389.00 | 58-08-2 |
| AB120241 | U0126 | Selective MKK inhibitor | 5mg | 1776.00 | 109511-58-2 |
| AB120241 | U0126 | Selective MKK inhibitor | 25mg | 7770.00 | 109511-58-2 |
| AB120242 | Flumazenil | Benzodiazepine antagonist | 10mg | 777.00 | 78755-81-4 |
| AB120242 | Flumazenil | Benzodiazepine antagonist | 50mg | 3386.00 | 78755-81-4 |
| AB120243 | LY 294002 | PI-3 kinase inhibitor | 5mg | 1110.00 | 154447-36-6 |
| AB120243 | LY 294002 | PI-3 kinase inhibitor | 25mg | 4884.00 | 154447-36-6 |
| AB120244 | VU0155041 | PAM for mGluR4 | 10mg | 389.00 | |
| AB120244 | VU0155041 | PAM for mGluR4 | 50mg | 1499.00 | |
| AB120245 | MMPIP | mGlu7 allosteric antagonist | 1mg | 611.00 | 479077-02-6 |
| AB120245 | MMPIP | mGlu7 allosteric antagonist | 10mg | 1610.00 | 479077-02-6 |
| AB120245 | MMPIP | mGlu7 allosteric antagonist | 50mg | 6993.00 | 479077-02-6 |
| AB120246 | Neuropeptide S (rat) | NPS receptor agonist | 1mg | 3996.00 | 412938-75-1 |
| AB120247 | Quercetin | Anti-oxidative flavonoid | 100mg | 500.00 | 6151-25-3 |
| AB120248 | VU0155041 sodium salt | PAM for mGluR4 (water soluble) | 10mg | 500.00 | |
| AB120248 | VU0155041 sodium salt | PAM for mGluR4 (water soluble) | 50mg | 1776.00 | |
| AB120249 | Memantine hydrochloride | NMDA antagonist, ion channel site | 50mg | 888.00 | 41100-52-1 |
| AB120250 | SKF 97541 | Highly potent GABAB agonist | 10mg | 1499.00 | 127729-35-5 |
| AB120250 | SKF 97541 | Highly potent GABAB agonist | 50mg | 6383.00 | 127729-35-5 |
| AB120251 | ACEA (Arachidonyl-2-chloroethylamide) | Potent, selective CB1 agonist | 5mg | 611.00 | 220556-69-4 |
| AB120251 | ACEA (Arachidonyl-2-chloroethylamide) | Potent, selective CB1 agonist | 25mg | 2387.00 | 220556-69-4 |
| AB120252 | (R,S)-MCPG sodium salt | Group I /II metabotropic glutamate antagonist; water soluble | 10mg | 1388.00 | |
| AB120252 | (R,S)-MCPG sodium salt | Group I /II metabotropic glutamate antagonist; water soluble | 50mg | 5772.00 | |
| AB120253 | DL-AP4 sodium salt | Broad spectrum glutamate antagonist; water soluble | 1g | 5883.00 | |
| AB120253 | DL-AP4 sodium salt | Broad spectrum glutamate antagonist; water soluble | 100mg | 777.00 | |
| AB120254 | 5,7-Dichlorokynurenic acid sodium salt | NMDA receptor glycine site antagonist; water soluble | 10mg | 777.00 | |
| AB120254 | 5,7-Dichlorokynurenic acid sodium salt | NMDA receptor glycine site antagonist; water soluble | 50mg | 3386.00 | |
| AB120254 | 5,7-Dichlorokynurenic acid sodium salt | NMDA receptor glycine site antagonist; water soluble | 100mg | 5661.00 | |
| AB120255 | 7-Chlorokynurenic acid sodium salt | NMDA receptor glycine site antagonist; water soluble | 10mg | 777.00 | |
| AB120255 | 7-Chlorokynurenic acid sodium salt | NMDA receptor glycine site antagonist; water soluble | 50mg | 3386.00 | |
| AB120256 | Kynurenic acid sodium salt | Endogenous ionotropic / nicotinic antagonist; water soluble | 1g | 611.00 | |
| AB120256 | Kynurenic acid sodium salt | Endogenous ionotropic / nicotinic antagonist; water soluble | 5g | 2886.00 | |
| AB120257 | Philanthotoxin-7,4 (PhTx-74) | GluA1/GluA2 (formerly GluR1/2) inhibitor | 1mg | 777.00 | 401601-12-5 |
| AB120257 | Philanthotoxin-7,4 (PhTx-74) | GluA1/GluA2 (formerly GluR1/2) inhibitor | 10mg | 1776.00 | 401601-12-5 |
| AB120257 | Philanthotoxin-7,4 (PhTx-74) | GluA1/GluA2 (formerly GluR1/2) inhibitor | 50mg | 7493.00 | 401601-12-5 |
| AB120258 | 1-EBIO | Activator of Ca2+-activated K+ channels and CFTR channels | 10mg | 611.00 | 10045-45-1 |
| AB120258 | 1-EBIO | Activator of Ca2+-activated K+ channels and CFTR channels | 50mg | 2387.00 | 10045-45-1 |
| AB120259 | SNX 482 | R-Type Ca2+ (Cav2.3) channel blocker | 10ug | 1499.00 | 203460-30-4 |
| AB120259 | SNX 482 | R-Type Ca2+ (Cav2.3) channel blocker | 100ug | 5273.00 | 203460-30-4 |
| AB120260 | Diltiazem | L-type Ca2+ channel antagonist | 1g | 777.00 | 33286-22-5 |
| AB120264 | Ruthenium red | Calcium signalling inhibitor | 100mg | 777.00 | 11103-72-3 |
| AB120266 | Diazoxide | Selective KIR6.x (ATP-sensitive K+ channel) activator | 100mg | 500.00 | 364-98-7 |
| AB120267 | Glibenclamide (Glyburide) | K+ channel blocker | 100mg | 500.00 | 10238-21-8 |
| AB120268 | Apamin | Blocker of small conductance Ca2+-activated K+ channels | 500ug | 1776.00 | 24345-16-2 |
| AB120269 | Charybdotoxin | K+ channel blocker | 10ug | 1110.00 | 95751-30-7 |
| AB120269 | Charybdotoxin | K+ channel blocker | 100ug | 3497.00 | 95751-30-7 |
| AB120270 | Terfenadine | K+ channel blocker. H1 antagonist. | 100mg | 1610.00 | 50679-08-8 |
| AB120271 | DL-AP5 sodium salt | NMDA glutamate site antagonist. Water soluble form. | 10mg | 611.00 | |
| AB120271 | DL-AP5 sodium salt | NMDA glutamate site antagonist. Water soluble form. | 50mg | 2775.00 | |
| AB120272 | Riluzole (PK 26124) | Neuroprotective agent. Modulates glutamate transmission. | 10mg | 389.00 | 1744-22-5 |
| AB120272 | Riluzole (PK 26124) | Neuroprotective agent. Modulates glutamate transmission. | 50mg | 999.00 | 1744-22-5 |
| AB120275 | Tetraethylammonium chloride (TEA) | Non-selective K+ channel blocker | 5g | 389.00 | 56-34-8 |
| AB120275 | Tetraethylammonium chloride (TEA) | Non-selective K+ channel blocker | 25g | 500.00 | 56-34-8 |
| AB120275 | Tetraethylammonium chloride (TEA) | Non-selective K+ channel blocker | 100g | 1110.00 | 56-34-8 |
| AB120276 | tBuBHQ (BHQ) | Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor | 100mg | 500.00 | 88-58-4 |
| AB120276 | tBuBHQ (BHQ) | Sarco-endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor | 500mg | 2109.00 | 88-58-4 |
| AB120278 | Tolbutamide | K+ channel blocker | 100mg | 389.00 | 64-77-7 |
| AB120279 | Veratridine | Na+ channel opener | 10mg | 888.00 | 71-62-5 |
| AB120279 | Veratridine | Na+ channel opener | 50mg | 3608.00 | 71-62-5 |
| AB120280 | SKF 96365 | Blocker of TRP cation channels. Inhibits capacitative Ca2+ entry. | 10mg | 1499.00 | 130495-35-1 |
| AB120280 | SKF 96365 | Blocker of TRP cation channels. Inhibits capacitative Ca2+ entry. | 50mg | 6383.00 | 130495-35-1 |
| AB120281 | Amiloride hydrochloride | eNaC blocker | 100mg | 500.00 | 2016-88-8 |
| AB120282 | A 803467 | Selective NaV1.8 channel blocker | 10mg | 1110.00 | 944261-79-4 |
| AB120282 | A 803467 | Selective NaV1.8 channel blocker | 50mg | 4385.00 | 944261-79-4 |
| AB120284 | KB-R7943 | NCX inhibitor. TRPC blocker. | 10mg | 1499.00 | 182004-65-5 |
| AB120284 | KB-R7943 | NCX inhibitor. TRPC blocker. | 50mg | 5994.00 | 182004-65-5 |
| AB120285 | S-Nitrosoglutathione (SNOG) | NO donor | 10mg | 777.00 | 57564-91-7 |
| AB120285 | S-Nitrosoglutathione (SNOG) | NO donor | 50mg | 2498.00 | 57564-91-7 |
| AB120286 | Thapsigargin | Ca2+-ATPase inhibitor | 1mg | 888.00 | 67526-95-8 |
| AB120287 | A23187 (Calcimycin) | Ca2+ ionophore | 10mg | 1388.00 | 52665-69-7 |
| AB120287 | A23187 (Calcimycin) | Ca2+ ionophore | 50mg | 3996.00 | 52665-69-7 |
| AB120289 | TMCB | Selective CK2 inhibitor | 10mg | 1110.00 | 905105-89-7 |
| AB120289 | TMCB | Selective CK2 inhibitor | 50mg | 4496.00 | 905105-89-7 |
| AB120290 | Ro 25-6981 maleate salt | NR2B antagonist | 1mg | 611.00 | 169274-78-6 |
| AB120290 | Ro 25-6981 maleate salt | NR2B antagonist | 10mg | 1610.00 | 169274-78-6 |
| AB120290 | Ro 25-6981 maleate salt | NR2B antagonist | 50mg | 6660.00 | 169274-78-6 |
| AB120292 | Exo-1 | Vesicular trafficking inhibitor | 10mg | 999.00 | 461681-88-9 |
| AB120292 | Exo-1 | Vesicular trafficking inhibitor | 50mg | 4107.00 | 461681-88-9 |
| AB120293 | YM 202074 | mGlu1 antagonist | 10mg | 1610.00 | 299900-83-7 |
| AB120293 | YM 202074 | mGlu1 antagonist | 50mg | 7493.00 | 299900-83-7 |
| AB120295 | NS 398 | COX-2 inhibitor | 10mg | 1499.00 | 123653-11-2 |
| AB120295 | NS 398 | COX-2 inhibitor | 50mg | 6383.00 | 123653-11-2 |
| AB120296 | Tunicamycin from Streptomyces sp | Antibiotic. Protein glycosylation inhibitor | 10mg | 1499.00 | 11089-65-9 |
| AB120296 | Tunicamycin from Streptomyces sp | Antibiotic. Protein glycosylation inhibitor | 50mg | 6161.00 | 11089-65-9 |
| AB120297 | Phorbol 12-myristate 13-acetate (PMA) | PKC activator | 1mg | 500.00 | 16561-29-8 |
| AB120297 | Phorbol 12-myristate 13-acetate (PMA) | PKC activator | 5mg | 1776.00 | 16561-29-8 |
| AB120297 | Phorbol 12-myristate 13-acetate (PMA) | PKC activator | 25mg | 7160.00 | 16561-29-8 |
| AB120299 | Brefeldin A | Inihibitor of ADP-ribosylation factor | 5mg | 1277.00 | 20350-15-6 |
| AB120299 | Brefeldin A | Inihibitor of ADP-ribosylation factor | 25mg | 5495.00 | 20350-15-6 |
| AB120300 | Cyclopiazonic acid from Penicillium grisefulvum | Ca2+-ATPase inhibitor | 10mg | 1277.00 | 18172-33-3 |
| AB120300 | Cyclopiazonic acid from Penicillium grisefulvum | Ca2+-ATPase inhibitor | 50mg | 5106.00 | 18172-33-3 |
| AB120301 | Amyloid beta (1-42) (human) | Predominant amyloid-beta protein fragment | 1mg | 4385.00 | 107761-42-2 |
| AB120301 | Amyloid beta (1-42) (human) | Predominant amyloid-beta protein fragment | 100ug | 1277.00 | 107761-42-2 |
| AB120304 | Purvalanol A | Potent CDK inhibitor | 1mg | 888.00 | 212844-53-6 |
| AB120304 | Purvalanol A | Potent CDK inhibitor | 10mg | 1887.00 | 212844-53-6 |
| AB120304 | Purvalanol A | Potent CDK inhibitor | 50mg | 8381.00 | 212844-53-6 |
| AB120305 | Purvalanol B | CDK2 inhibitor | 10mg | 1887.00 | 212844-54-7 |
| AB120305 | Purvalanol B | CDK2 inhibitor | 50mg | 8381.00 | 212844-54-7 |
| AB120306 | HA-1077 | ROCK2 inhibitor | 10mg | 1277.00 | 103745-39-7 |
| AB120306 | HA-1077 | ROCK2 inhibitor | 50mg | 5384.00 | 103745-39-7 |
| AB120307 | gamma-DGG (gamma-D-glutamylglycine) | Ionotropic glutamate antagonist. Low affinity AMPA antagonist. | 50mg | 1277.00 | 6729-55-1 |
| AB120308 | PP2 | Src and RIP2 kinase inhibitor | 1mg | 888.00 | 172889-27-9 |
| AB120308 | PP2 | Src and RIP2 kinase inhibitor | 5mg | 1388.00 | 172889-27-9 |
| AB120308 | PP2 | Src and RIP2 kinase inhibitor | 10mg | 2276.00 | 172889-27-9 |
| AB120309 | UCPH-101 | Potent, selective EAAT1 inhibitor | 1mg | 999.00 | 1118460-77-7 |
| AB120309 | UCPH-101 | Potent, selective EAAT1 inhibitor | 10mg | 1887.00 | 1118460-77-7 |
| AB120310 | Vigabatrin | Irreversible inhibitor of GABA transaminase | 10mg | 777.00 | 60643-86-8 |
| AB120310 | Vigabatrin | Irreversible inhibitor of GABA transaminase | 50mg | 2886.00 | 60643-86-8 |
| AB120311 | Etomidate | GABAA agonist | 10mg | 1110.00 | 33125-97-2 |
| AB120311 | Etomidate | GABAA agonist | 50mg | 4884.00 | 33125-97-2 |
| AB120312 | Nipecotic acid | GABA reuptake inhibitor | 1g | 1110.00 | 60252-41-7 |
| AB120312 | Nipecotic acid | GABA reuptake inhibitor | 5g | 2387.00 | 60252-41-7 |
| AB120312 | Nipecotic acid | GABA reuptake inhibitor | 100mg | 500.00 | 60252-41-7 |
| AB120314 | Furosemide | Inhibitor of the Na+/2Cl-/K+ cotransporter. Also GABAA antagonist. | 1g | 389.00 | 54-31-9 |
| AB120314 | Furosemide | Inhibitor of the Na+/2Cl-/K+ cotransporter. Also GABAA antagonist. | 5g | 1499.00 | 54-31-9 |
| AB120314 | Furosemide | Inhibitor of the Na+/2Cl-/K+ cotransporter. Also GABAA antagonist. | 10g | 2109.00 | 54-31-9 |
| AB120315 | Picrotoxin | GABAA antagonist | 1g | 389.00 | 124-87-8 |
| AB120315 | Picrotoxin | GABAA antagonist | 5g | 1610.00 | 124-87-8 |
| AB120316 | Aniracetam | AMPA receptor potentiator | 50mg | 1110.00 | 72432-10-1 |
| AB120316 | Aniracetam | AMPA receptor potentiator | 250mg | 4496.00 | 72432-10-1 |
| AB120317 | NNC 05-2090 | GABA uptake inhibitor | 10mg | 1776.00 | 184845-43-0 |
| AB120317 | NNC 05-2090 | GABA uptake inhibitor | 50mg | 7770.00 | 184845-43-0 |
| AB120318 | rac BHFF | Potent, selective GABAB positive allosteric modulator | 10mg | 1277.00 | 123557-91-5 |
| AB120318 | rac BHFF | Potent, selective GABAB positive allosteric modulator | 50mg | 5106.00 | 123557-91-5 |
| AB120325 | (R)-Baclofen | Selective GABAB agonist. Active enantiomer. | 10mg | 777.00 | 69308-37-8 |
| AB120325 | (R)-Baclofen | Selective GABAB agonist. Active enantiomer. | 50mg | 2997.00 | 69308-37-8 |
| AB120325 | (R)-Baclofen | Selective GABAB agonist. Active enantiomer. | 250mg | 8159.00 | 69308-37-8 |
| AB120326 | SKF89976A hydrochloride | Highly selective GAT-1 inhibitor | 10mg | 999.00 | 85375-15-1 |
| AB120326 | SKF89976A hydrochloride | Highly selective GAT-1 inhibitor | 50mg | 4107.00 | 85375-15-1 |
| AB120327 | Saclofen | GABAB antagonist | 10mg | 1610.00 | 125464-42-8 |
| AB120327 | Saclofen | GABAB antagonist | 50mg | 6993.00 | 125464-42-8 |
| AB120328 | EMD 386088 hydrochloride | Potent 5HT6 agonist | 10mg | 1277.00 | 54635-62-0 |
| AB120328 | EMD 386088 hydrochloride | Potent 5HT6 agonist | 50mg | 5106.00 | 54635-62-0 |
| AB120329 | 3-APPA (CGP 27492) | Potent, selective GABAB agonist | 10mg | 1277.00 | 103680-47-3 |
| AB120329 | 3-APPA (CGP 27492) | Potent, selective GABAB agonist | 50mg | 5106.00 | 103680-47-3 |
| AB120330 | CGP 52432 | Potent GABAB antagonist | 10mg | 1887.00 | 139667-74-6 |
| AB120330 | CGP 52432 | Potent GABAB antagonist | 50mg | 8159.00 | 139667-74-6 |
| AB120331 | FFN511 (Fluorescent False Neurotransmitter 511) | Fluorescent false neurotransmitter; highly efficient optical tracer of dopamine | 1mg | 1277.00 | 1004548-96-2 |
| AB120331 | FFN511 (Fluorescent False Neurotransmitter 511) | Fluorescent false neurotransmitter; highly efficient optical tracer of dopamine | 5mg | 1998.00 | 1004548-96-2 |
| AB120332 | SB 399885 hydrochloride | Potent, selective 5HT6 antagonist | 10mg | 1776.00 | 402713-80-8 |
| AB120332 | SB 399885 hydrochloride | Potent, selective 5HT6 antagonist | 50mg | 7493.00 | 402713-80-8 |
| AB120333 | D890 | Intracellular Ca2+ channel blocker | 10mg | 611.00 | |
| AB120333 | D890 | Intracellular Ca2+ channel blocker | 50mg | 2498.00 | |
| AB120334 | Propofol (ICI 35868) | GABAA agonist | 1g | 777.00 | 2078-54-8 |
| AB120335 | A 769662 | AMP-activated protein kinase activator | 10mg | 1610.00 | 844499-71-4 |
| AB120335 | A 769662 | AMP-activated protein kinase activator | 50mg | 7160.00 | 844499-71-4 |
| AB120336 | GYKI 52466 | Selective non-competitive AMPA antagonist | 10mg | 1277.00 | 102771-26-6 |
| AB120336 | GYKI 52466 | Selective non-competitive AMPA antagonist | 50mg | 5384.00 | 102771-26-6 |
| AB120337 | CGP 55845 hydrochloride | Potent, selective GABAB antagonist | 10mg | 1776.00 | 149184-22-5 |
| AB120337 | CGP 55845 hydrochloride | Potent, selective GABAB antagonist | 50mg | 7770.00 | 149184-22-5 |
| AB120338 | Domoic acid | Kainate agonist. Neurotoxin. | 1mg | 1499.00 | 14277-97-5 |
| AB120338 | Domoic acid | Kainate agonist. Neurotoxin. | 5mg | 5384.00 | 14277-97-5 |
| AB120339 | Resiniferatoxin | Ultrapotent TRPV1 agonist | 1mg | 1277.00 | 57444-62-9 |
| AB120340 | 5'-Iodoresiniferatoxin | Selective TRPV1 antagonist. Some partial agonist activity reported. | 1mg | 3386.00 | |
| AB120341 | H89 dihydrochloride | Kinase inhibitor | 1mg | 611.00 | 127243-85-0 |
| AB120341 | H89 dihydrochloride | Kinase inhibitor | 10mg | 1610.00 | 127243-85-0 |
| AB120341 | H89 dihydrochloride | Kinase inhibitor | 50mg | 6993.00 | 127243-85-0 |
| AB120342 | Org 27569 | Potent CB1 receptor allosteric modulator | 10mg | 1610.00 | 868273-06-7 |
| AB120342 | Org 27569 | Potent CB1 receptor allosteric modulator | 50mg | 6660.00 | 868273-06-7 |
| AB120344 | Gp 1a | Highly potent and selective CB2 agonist | 10mg | 1998.00 | |
| AB120344 | Gp 1a | Highly potent and selective CB2 agonist | 50mg | 8658.00 | |
| AB120345 | Palmitoylethanolamide | Potent, selective GPR55 agonist | 10mg | 611.00 | 544-31-0 |
| AB120345 | Palmitoylethanolamide | Potent, selective GPR55 agonist | 50mg | 2775.00 | 544-31-0 |
| AB120346 | N-Arachidonylglycine (NAGly) | T-type Ca2+ channel blocker. Endogenous GLYT2 inhibitor. | 5mg | 999.00 | 179113-91-8 |
| AB120346 | N-Arachidonylglycine (NAGly) | T-type Ca2+ channel blocker. Endogenous GLYT2 inhibitor. | 25mg | 4107.00 | 179113-91-8 |
| AB120346 | N-Arachidonylglycine (NAGly) | T-type Ca2+ channel blocker. Endogenous GLYT2 inhibitor. | 100mg | 9380.00 | 179113-91-8 |
| AB120349 | GR 125743 | 5HT1B/1D antagonist | 10mg | 999.00 | 148547-33-5 |
| AB120350 | AACOCF3 (Arachidonyl trifluoromethyl ketone) | Phospholipase-A2 inhibitor | 5mg | 777.00 | 149301-79-1 |
| AB120350 | AACOCF3 (Arachidonyl trifluoromethyl ketone) | Phospholipase-A2 inhibitor | 25mg | 2997.00 | 149301-79-1 |
| AB120354 | Flufenamic acid | NSAID. COX inhibitor, channel blocker. | 100mg | 278.00 | 530-78-9 |
| AB120355 | Clioquinol | Metal chelator and ionophore | 1g | 2498.00 | 522629-08-9 |
| AB120355 | Clioquinol | Metal chelator and ionophore | 100mg | 389.00 | 522629-08-9 |
| AB120356 | Mifepristone (RU486) | Mifepristone (RU486) | 100mg | 777.00 | 84371-65-3 |
| AB120356 | Mifepristone (RU486) | Mifepristone (RU486) | 500mg | 2997.00 | 84371-65-3 |
| AB120357 | Kaempferol | Phytoestrogen. Proapoptotic agent. | 10mg | 500.00 | 520-18-3 |
| AB120357 | Kaempferol | Phytoestrogen. Proapoptotic agent. | 50mg | 777.00 | 520-18-3 |
| AB120358 | AICAR (Acadesine/AICA riboside) | Cell-permeable activator of AMP-activated protein kinase | 50mg | 999.00 | 2627-69-2 |
| AB120358 | AICAR (Acadesine/AICA riboside) | Cell-permeable activator of AMP-activated protein kinase | 250mg | 2609.00 | 2627-69-2 |
| AB120359 | GABA | Inhibitory neurotransmitter | 1g | 389.00 | 56-12-2 |
| AB120359 | GABA | Inhibitory neurotransmitter | 5g | 888.00 | 56-12-2 |
| AB120361 | (R)-(+)-Methanandamide (ethanol solution) | Stable anandamide analogue. CB1 receptor agonist. | 5mg | 611.00 | 157182-49-5 |
| AB120361 | (R)-(+)-Methanandamide (ethanol solution) | Stable anandamide analogue. CB1 receptor agonist. | 25mg | 2109.00 | 157182-49-5 |
| AB120363 | CDPPB | PAM for mGlu5. Active in vivo. | 10mg | 1610.00 | 781652-57-1 |
| AB120363 | CDPPB | PAM for mGlu5. Active in vivo. | 50mg | 6660.00 | 781652-57-1 |
| AB120364 | NNC 711 | Potent, selective GAT-1 inhibitor | 10mg | 1610.00 | 145645-62-1 |
| AB120364 | NNC 711 | Potent, selective GAT-1 inhibitor | 50mg | 7160.00 | 145645-62-1 |
| AB120365 | CGP 57380 | MNK inhibitor | 1mg | 777.00 | 522629-08-9 |
| AB120365 | CGP 57380 | MNK inhibitor | 10mg | 1776.00 | 522629-08-9 |
| AB120365 | CGP 57380 | MNK inhibitor | 50mg | 7493.00 | 522629-08-9 |
| AB120368 | DR2313 (PARP Inhibitor XI) | Potent, brain-penetrant and water-soluble PARP inhibitor | 1mg | 500.00 | 284028-90-6 |
| AB120368 | DR2313 (PARP Inhibitor XI) | Potent, brain-penetrant and water-soluble PARP inhibitor | 10mg | 1388.00 | 284028-90-6 |
| AB120368 | DR2313 (PARP Inhibitor XI) | Potent, brain-penetrant and water-soluble PARP inhibitor | 50mg | 5772.00 | 284028-90-6 |
| AB120369 | Zonisamide | Non-selective Na+ / Ca2+channel blocker | 10mg | 999.00 | 68291-97-4 |
| AB120369 | Zonisamide | Non-selective Na+ / Ca2+channel blocker | 50mg | 3996.00 | 68291-97-4 |
| AB120370 | Ionomycin (free acid) | Ca2+ ionophore | 1mg | 1277.00 | 56092-81-0 |
| AB120370 | Ionomycin (free acid) | Ca2+ ionophore | 5mg | 4995.00 | 56092-81-0 |
| AB120371 | NS309 | Activates Ca2+-activated K+ channels | 10mg | 777.00 | 18711-16-5 |
| AB120371 | NS309 | Activates Ca2+-activated K+ channels | 50mg | 2997.00 | 18711-16-5 |
| AB120374 | Ro 31-8220 mesylate (Bisindolylmaleimide IX) | Protein kinase inhibitor | 1mg | 611.00 | 125314-64-9 |
| AB120374 | Ro 31-8220 mesylate (Bisindolylmaleimide IX) | Protein kinase inhibitor | 10mg | 2109.00 | 125314-64-9 |
| AB120374 | Ro 31-8220 mesylate (Bisindolylmaleimide IX) | Protein kinase inhibitor | 50mg | 7493.00 | 125314-64-9 |
| AB120375 | Okadaic acid | PP1 and PP2A inhibitor | 25ug | 999.00 | 78111-17-8 |
| AB120375 | Okadaic acid | PP1 and PP2A inhibitor | 100ug | 2498.00 | 78111-17-8 |
| AB120377 | Rottlerin | Kinase inhibitor | 10mg | 777.00 | 82-08-6 |
| AB120377 | Rottlerin | Kinase inhibitor | 50mg | 3386.00 | 82-08-6 |
| AB120378 | PK11195 | Peripheral benzodiazepine receptor antagonist | 10mg | 777.00 | 85532-75-8 |
| AB120378 | PK11195 | Peripheral benzodiazepine receptor antagonist | 50mg | 2886.00 | 85532-75-8 |
| AB120379 | Iberiotoxin | Selective blocker of the high-conductance, Ca2+-activated K+ channel | 100ug | 2775.00 | 129203-60-7 |
| AB120380 | NGHVYEKLSSIE (Interfering peptide) | Competes with AP-2 binding to NR2B | 1mg | 1277.00 | |
| AB120381 | NGHVAEKLSSIE (Control Peptide) | Control peptide for ab120380 | 1mg | 1277.00 | |
| AB120382 | Z-VAD-FMK | Irreversible general caspase inhibitor | 1mg | 2109.00 | |
| AB120382 | Z-VAD-FMK | Irreversible general caspase inhibitor | 5mg | 7493.00 | |
| AB120383 | UDP sodium salt (Uridine 5'-diphosphate) | P2Y6 agonist. P2Y14 ligand. | 100mg | 611.00 | 21931-53-3 |
| AB120383 | UDP sodium salt (Uridine 5'-diphosphate) | P2Y6 agonist. P2Y14 ligand. | 500mg | 2498.00 | 21931-53-3 |
| AB120384 | UDP-glucose | Highly potent P2Y14 agonist | 1g | 2498.00 | 28053-08-9 |
| AB120384 | UDP-glucose | Highly potent P2Y14 agonist | 100mg | 611.00 | 28053-08-9 |
| AB120385 | ATP disodium salt | P2 receptor agonist. Signalling molecule. | 1g | 389.00 | 34369-07-8 |
| AB120385 | ATP disodium salt | P2 receptor agonist. Signalling molecule. | 5g | 999.00 | 34369-07-8 |
| AB120385 | ATP disodium salt | P2 receptor agonist. Signalling molecule. | 10g | 1776.00 | 34369-07-8 |
| AB120385 | ATP disodium salt | P2 receptor agonist. Signalling molecule. | 25g | 3386.00 | 34369-07-8 |
| AB120386 | Sodium orthovanadate (for Decavanadate solution) | Broad spectrum inhibitor of tyrosine phosphatases | 1g | 278.00 | 13721-39-6 |
| AB120386 | Sodium orthovanadate (for Decavanadate solution) | Broad spectrum inhibitor of tyrosine phosphatases | 5g | 500.00 | 13721-39-6 |
| AB120387 | (+/-)-Clopidogrel | Potent, selective P2Y12 antagonist | 10mg | 1388.00 | 135046-48-9 |
| AB120387 | (+/-)-Clopidogrel | Potent, selective P2Y12 antagonist | 50mg | 5772.00 | 135046-48-9 |
| AB120388 | Topotecan hydrochloride (SK&F 104864) | Topoisomerase inhibitor | 10mg | 500.00 | 119413-54-6 |
| AB120388 | Topotecan hydrochloride (SK&F 104864) | Topoisomerase inhibitor | 50mg | 2109.00 | 119413-54-6 |
| AB120389 | Brilliant Blue G | Potent, noncompetitive P2X7 antagonist | 1g | 1776.00 | 6104-58-1 |
| AB120389 | Brilliant Blue G | Potent, noncompetitive P2X7 antagonist | 100mg | 389.00 | 6104-58-1 |
| AB120390 | Equol | Metabolite of phytoestrogen daidzein | 5mg | 999.00 | 94105-90-5 |
| AB120390 | Equol | Metabolite of phytoestrogen daidzein | 25mg | 3774.00 | 94105-90-5 |
| AB120391 | Daidzein | Phytoestrogen | 50mg | 888.00 | 486-66-8 |
| AB120392 | Cyclopamine | Hh signaling inhibitor | 1mg | 1610.00 | 4449-51-8 |
| AB120392 | Cyclopamine | Hh signaling inhibitor | 5mg | 6383.00 | 4449-51-8 |
| AB120393 | Risperidone | Atypical antipsychotic. 5HT2A / D2 antagonist. | 10mg | 999.00 | 106266-06-2 |
| AB120393 | Risperidone | Atypical antipsychotic. 5HT2A / D2 antagonist. | 50mg | 4107.00 | 106266-06-2 |
| AB120394 | Ziprasidone (CP 88059) | Atypical antipsychotic. 5HT2A / D2 antagonist. | 10mg | 1277.00 | 138982-67-9 |
| AB120394 | Ziprasidone (CP 88059) | Atypical antipsychotic. 5HT2A / D2 antagonist. | 50mg | 5384.00 | 138982-67-9 |
| AB120395 | GW791343 | P2X7 allosteric modulator | 10mg | 1610.00 | 1019779-04-4 |
| AB120395 | GW791343 | P2X7 allosteric modulator | 50mg | 7160.00 | 1019779-04-4 |
| AB120396 | DPCPX | Potent A1 antagonist | 25mg | 611.00 | 102146-07-6 |
| AB120396 | DPCPX | Potent A1 antagonist | 100mg | 1277.00 | 102146-07-6 |
| AB120397 | MRS 1754 | Selective A2B antagonist | 10mg | 1776.00 | 264622-58-4 |
| AB120397 | MRS 1754 | Selective A2B antagonist | 50mg | 7493.00 | 264622-58-4 |
| AB120398 | N6-Cyclopentyladenosine (CPA) | Potent, selective A1 agonist | 25mg | 500.00 | 41552-82-3 |
| AB120398 | N6-Cyclopentyladenosine (CPA) | Potent, selective A1 agonist | 100mg | 1887.00 | 41552-82-3 |
| AB120400 | LY 341495 sodium salt | Water-soluble, potent, selective group II antagonist. Group III antagonist at higher concentrations. | 1mg | 999.00 | |
| AB120400 | LY 341495 sodium salt | Water-soluble, potent, selective group II antagonist. Group III antagonist at higher concentrations. | 50mg | 11045.00 | |
| AB120403 | beta-Nicotinamide adenine dinucleotide (beta-NAD) | Coenzyme and enzyme substrate. P2Y11 agonist. | 1g | 3497.00 | 53-84-9 |
| AB120403 | beta-Nicotinamide adenine dinucleotide (beta-NAD) | Coenzyme and enzyme substrate. P2Y11 agonist. | 25mg | 389.00 | 53-84-9 |
| AB120403 | beta-Nicotinamide adenine dinucleotide (beta-NAD) | Coenzyme and enzyme substrate. P2Y11 agonist. | 250mg | 1277.00 | 53-84-9 |
| AB120404 | AM630 (Iodopravadoline) | CB2 antagonist / inverse agonist | 10mg | 1776.00 | 164178-33-0 |
| AB120404 | AM630 (Iodopravadoline) | CB2 antagonist / inverse agonist | 50mg | 7770.00 | 164178-33-0 |
| AB120405 | O-1918 | Antagonist of the non-CB1 vascular cannabinoid receptor | 10mg | 1776.00 | 536697-79-7 |
| AB120405 | O-1918 | Antagonist of the non-CB1 vascular cannabinoid receptor | 50mg | 6993.00 | 536697-79-7 |
| AB120407 | O-1602 | Potent, selective GPR55 agonist | 10mg | 1776.00 | 317321-41-8 |
| AB120407 | O-1602 | Potent, selective GPR55 agonist | 50mg | 6993.00 | 317321-41-8 |
| AB120408 | RuBi-Glutamate | Novel caged-glutamate compound, uncaged by visible light | 10mg | 1887.00 | |
| AB120409 | RuBi-GABA | Novel caged-GABA compound, uncaged by visible light | 10mg | 1887.00 | |
| AB120410 | RuBi-4AP | Caged K+ channel blocker, uncaged by visible light | 10mg | 1887.00 | |
| AB120411 | Endomorphin-1 | Highly potent and selective me agonist | 5mg | 999.00 | 189388-22-5 |
| AB120412 | Dynorphin A | Potent kappa agonist | 1mg | 1887.00 | 80448-90-4 |
| AB120413 | A 438079 | Potent, competitive P2X7 receptor antagonist | 10mg | 1499.00 | 899507-36-9 |
| AB120413 | A 438079 | Potent, competitive P2X7 receptor antagonist | 50mg | 6383.00 | 899507-36-9 |
| AB120414 | MRS 2179 | Potent, selective P2Y1 antagonist | 10mg | 1887.00 | 101204-49-3 |
| AB120414 | MRS 2179 | Potent, selective P2Y1 antagonist | 50mg | 8381.00 | 101204-49-3 |
| AB120415 | NF 449 | Highly selective, potent P2X1 receptor antagonist | 10mg | 1776.00 | 389142-38-5 |
| AB120415 | NF 449 | Highly selective, potent P2X1 receptor antagonist | 50mg | 7493.00 | 389142-38-5 |
| AB120416 | Strychnine hydrochloride | Glycine antagonist | 100mg | 777.00 | 1421-86-9 |
| AB120417 | CTOP | Potent, selective µ opioid receptor antagonist. | 1mg | 1499.00 | |
| AB120419 | K252a | Highly potent inhibitor of protein and CAM kinases | 1mg | 8769.00 | 99533-80-9 |
| AB120419 | K252a | Highly potent inhibitor of protein and CAM kinases | 200ug | 2276.00 | 99533-80-9 |
| AB120420 | Buspirone hydrochloride | 5HT1A agonist. Anxiolytic. | 1g | 611.00 | 33386-08-2 |
| AB120420 | Buspirone hydrochloride | 5HT1A agonist. Anxiolytic. | 5g | 2109.00 | 33386-08-2 |
| AB120421 | KN-62 | CaM kinase II inhibitor. P2X7 antagonist. | 1mg | 1277.00 | 127191-97-3 |
| AB120421 | KN-62 | CaM kinase II inhibitor. P2X7 antagonist. | 5mg | 2775.00 | 127191-97-3 |
| AB120422 | Suramin hexasodium salt | Non-selective P2 purinergic antagonist | 100mg | 777.00 | 129-46-4 |
| AB120422 | Suramin hexasodium salt | Non-selective P2 purinergic antagonist | 500mg | 3608.00 | 129-46-4 |
| AB120423 | KT5823 | Potent, selective inhibitor of PKG | 100ug | 1388.00 | 126643-37-6 |
| AB120424 | 8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP) | Cell permeable cAMP analogue, protein kinase modulator | 20mg | 888.00 | 93882-12-3 |
| AB120424 | 8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate (8-CPT-cAMP) | Cell permeable cAMP analogue, protein kinase modulator | 100mg | 2886.00 | 93882-12-3 |
| AB120425 | (+/-)-Blebbistatin | Potent, selective, inhibitor of myosin II | 5mg | 1277.00 | 674289-55-5 |
| AB120425 | (+/-)-Blebbistatin | Potent, selective, inhibitor of myosin II | 25mg | 4995.00 | 674289-55-5 |
| AB120428 | ZM 336372 | Potent, selective c-Raf inhibitor | 1mg | 389.00 | 208260-29-1 |
| AB120428 | ZM 336372 | Potent, selective c-Raf inhibitor | 10mg | 1776.00 | 208260-29-1 |
| AB120428 | ZM 336372 | Potent, selective c-Raf inhibitor | 50mg | 7493.00 | 208260-29-1 |
| AB120429 | Anandamide (in water soluble emulsion) | Endogenous cannabinoid in water soluble emulsion | 10mg | 1610.00 | 94421-68-8 |
| AB120429 | Anandamide (in water soluble emulsion) | Endogenous cannabinoid in water soluble emulsion | 50mg | 6993.00 | 94421-68-8 |
| AB120431 | Water soluble emulsion (blank) | Water soluble emulsion. Negative control. | 1millilitres | 777.00 | |
| AB120431 | Water soluble emulsion (blank) | Water soluble emulsion. Negative control. | 10 millilitres | 2498.00 | |
| AB120432 | Tertiapin Q | Potent inward rectifier K+ channel blocker | 1mg | 3608.00 | 252198-49-5 |
| AB120433 | Pep2m | Inhibitor of AMPA receptor trafficking | 2mg | 2886.00 | 243843-42-7 |
| AB120434 | 2-Chloro-N6-cyclopentyladenosine (CCPA) | Highly potent, selective A1 agonist | 10mg | 1277.00 | 37739-05-2 |
| AB120434 | 2-Chloro-N6-cyclopentyladenosine (CCPA) | Highly potent, selective A1 agonist | 50mg | 5106.00 | 37739-05-2 |
| AB120438 | IB-MECA | Highly potent and selective A3 agonist | 5mg | 1887.00 | 152918-18-8 |
| AB120438 | IB-MECA | Highly potent and selective A3 agonist | 25mg | 8159.00 | 152918-18-8 |
| AB120439 | SCH-58261 | Potent, highly selective A2A antagonist | 10mg | 1610.00 | 160098-96-4 |
| AB120439 | SCH-58261 | Potent, highly selective A2A antagonist | 50mg | 7160.00 | 160098-96-4 |
| AB120440 | NECA | Highly potent adenosine agonist | 10mg | 500.00 | 35920-39-9 |
| AB120440 | NECA | Highly potent adenosine agonist | 50mg | 1499.00 | 35920-39-9 |
| AB120442 | 8-(3-Chlorostyryl)caffeine | Selective A2A receptor antagonist. MAO-B inhibitor. | 10mg | 777.00 | 147700-11-6 |
| AB120442 | 8-(3-Chlorostyryl)caffeine | Selective A2A receptor antagonist. MAO-B inhibitor. | 50mg | 3386.00 | 147700-11-6 |
| AB120445 | MRS 2211 | Selective competitve P2Y13 antagonist | 10mg | 888.00 | |
| AB120445 | MRS 2211 | Selective competitve P2Y13 antagonist | 50mg | 4107.00 | |
| AB120446 | Anandamide-d4 (ethanol solution) | Internal standard for anandamide quantification | 1mg | 1887.00 | 946524-40-9 |
| AB120446 | Anandamide-d4 (ethanol solution) | Internal standard for anandamide quantification | 5mg | 4995.00 | 946524-40-9 |
| AB120448 | (-)-Cannabidiol | Common constituent of Cannabis | 10mg | 1499.00 | 13956-29-1 |
| AB120448 | (-)-Cannabidiol | Common constituent of Cannabis | 50mg | 5994.00 | 13956-29-1 |
| AB120449 | BAPTA sodium salt | Selective Ca2+ chelator | 1g | 1610.00 | 126824-24-6 |
| AB120449 | BAPTA sodium salt | Selective Ca2+ chelator | 5g | 5661.00 | 126824-24-6 |
| AB120449 | BAPTA sodium salt | Selective Ca2+ chelator | 250mg | 500.00 | 126824-24-6 |
| AB120450 | RuBi-nicotine | Novel, caged nicotine compound, uncaged by visible light | 5mg | 1610.00 | |
| AB120451 | Dipyridamole | Non selective phosphodiesterase (PDE) inhibitor | 1g | 389.00 | 58-32-2 |
| AB120451 | Dipyridamole | Non selective phosphodiesterase (PDE) inhibitor | 5g | 888.00 | 58-32-2 |
| AB120451 | Dipyridamole | Non selective phosphodiesterase (PDE) inhibitor | 10g | 1499.00 | 58-32-2 |
| AB120452 | Iodotubercidin | Potent, adenosine kinase inhibitor | 1mg | 1110.00 | 24386-93-4 |
| AB120452 | Iodotubercidin | Potent, adenosine kinase inhibitor | 5mg | 3608.00 | 24386-93-4 |
| AB120453 | CGS 21680 | Potent, selective A2A agonist | 10mg | 2387.00 | 124182-57-6 |
| AB120453 | CGS 21680 | Potent, selective A2A agonist | 50mg | 10268.00 | 124182-57-6 |
| AB120454 | NF023 | Competitive P2X1 receptor antagonist | 10mg | 1110.00 | 104869-31-0 |
| AB120454 | NF023 | Competitive P2X1 receptor antagonist | 50mg | 4607.00 | 104869-31-0 |
| AB120458 | HENECA | Selective A2A receptor agonist | 1mg | 999.00 | 141018-30-6 |
| AB120458 | HENECA | Selective A2A receptor agonist | 10mg | 2498.00 | 141018-30-6 |
| AB120459 | Mecamylamine hydrochloride | Non-competitive antagonist of nicotinic receptors | 10mg | 777.00 | 826-39-1 |
| AB120459 | Mecamylamine hydrochloride | Non-competitive antagonist of nicotinic receptors | 50mg | 3386.00 | 826-39-1 |
| AB120461 | Iminodyn-22™ | Potent, broad spectrum dynamin inhibitor | 5mg | 1998.00 | |
| AB120462 | Iminodyn-17? | Negative control for Iminodyn-22? | 5mg | 1998.00 | 1227697-48-4 |
| AB120463 | Dynole-34-2? | Potent dynamin I and dynamin II inhibitor | 5mg | 1998.00 | |
| AB120464 | Dynole-31-2? | Negative control for Dynole 34-2? | 5mg | 1998.00 | |
| AB120465 | RTIL-13? | Potent dynamin I and II inhibitor | 5mg | 1998.00 | 1009376-10-6 |
| AB120466 | MiTMAB™ | Cell permeable dynamin I and dynamin II inhibitor | 5mg | 1998.00 | 1119-97-7 |
| AB120467 | OcTMAB? | Cell permeable dynamin I and dynamin II inhibitor | 5mg | 1998.00 | 1120-02-1 |
| AB120469 | Acetylcholine chloride | Endogenous neurotransmitter active at acetylcholine receptors | 5g | 1887.00 | 60-31-1 |
| AB120469 | Acetylcholine chloride | Endogenous neurotransmitter active at acetylcholine receptors | 50mg | 611.00 | 60-31-1 |
| AB120470 | Bradykinin | Bradykinin receptor agonist | 1mg | 278.00 | 6846-03-3 |
| AB120470 | Bradykinin | Bradykinin receptor agonist | 5mg | 500.00 | 6846-03-3 |
| AB120470 | Bradykinin | Bradykinin receptor agonist | 10mg | 777.00 | 6846-03-3 |
| AB120470 | Bradykinin | Bradykinin receptor agonist | 25mg | 1499.00 | 6846-03-3 |
| AB120471 | Endothelin-1 (human, porcine) | Vasoconstrictor peptide | 10ug | 611.00 | 117399-94-7 |
| AB120471 | Endothelin-1 (human, porcine) | Vasoconstrictor peptide | 100ug | 1610.00 | 117399-94-7 |
| AB120471 | Endothelin-1 (human, porcine) | Vasoconstrictor peptide | 500ug | 6383.00 | 117399-94-7 |
| AB120472 | N6-Cyclohexyladenosine | Selective A1 receptor agonist | 50mg | 777.00 | 36396-99-3 |
| AB120472 | N6-Cyclohexyladenosine | Selective A1 receptor agonist | 250mg | 2997.00 | 36396-99-3 |
| AB120476 | Pro-Myristic Acid | Negative control for MiTMAB? and OcTMAB? | 5mg | 1998.00 | 43016-78-0 |
| AB120478 | Pifithrin-alpha-HBr | p53 inhibitor | 10mg | 1499.00 | 63208-82-2 |
| AB120478 | Pifithrin-alpha-HBr | p53 inhibitor | 50mg | 5994.00 | 63208-82-2 |
| AB120479 | Amyloid beta (1-40) (human) | Amyloid beta protein fragment. Implicated in Alzheimerrsquos disease. | 1mg | 2997.00 | 131438-79-4 |
| AB120479 | Amyloid beta (1-40) (human) | Amyloid beta protein fragment. Implicated in Alzheimerrsquos disease. | 5mg | 11877.00 | 131438-79-4 |
| AB120480 | Amyloid beta (25-35) (human) | Highly toxic amyloid beta protein fragment | 1mg | 1610.00 | 131602-53-4 |
| AB120481 | Amyloid beta (42-1) (human) | Inactive control for Amyloid beta (1-42) (ab120301) peptide | 1mg | 4496.00 | 317366-82-8 |
| AB120483 | Psalmotoxin-1 | Potent, selective ASIC1a blocker | 20ug | 611.00 | |
| AB120483 | Psalmotoxin-1 | Potent, selective ASIC1a blocker | 100ug | 2498.00 | |
| AB120484 | Tertiapin LQ | Potent, selective blocker of Kir1.1 channels. Tertiapin Q (ab120432) derivative. | 1mg | 1776.00 | |
| AB120485 | Levcromakalim | KATP channel activator. | 10mg | 1998.00 | 94535-50-9 |
| AB120485 | Levcromakalim | KATP channel activator. | 50mg | 8658.00 | 94535-50-9 |
| AB120486 | Cromakalim | KIR6.x (KATP) channel activator | 10mg | 1388.00 | 94470-67-4 |
| AB120486 | Cromakalim | KIR6.x (KATP) channel activator | 50mg | 5883.00 | 94470-67-4 |
| AB120487 | Z-VAD(OMe)-FMK | Cell permeable, irreversible pan-caspase inhibitor | 1mg | 2109.00 | |
| AB120487 | Z-VAD(OMe)-FMK | Cell permeable, irreversible pan-caspase inhibitor | 5mg | 5106.00 | |
| AB120488 | Z-D(OMe)E(OMe)VD(OMe)-FMK | Cell permeable caspase-3 inhibitor | 1mg | 2609.00 | |
| AB120488 | Z-D(OMe)E(OMe)VD(OMe)-FMK | Cell permeable caspase-3 inhibitor | 5mg | 10157.00 | |
| AB120489 | Z-LE(OMe)VD(OMe)-FMK | Cell permeable derivative of caspase-4 inhibitor Z-LEVD-FMK | 1mg | 1499.00 | |
| AB120489 | Z-LE(OMe)VD(OMe)-FMK | Cell permeable derivative of caspase-4 inhibitor Z-LEVD-FMK | 5mg | 5994.00 | |
| AB120490 | GYKI 53655 hydrochloride | Non-competitive AMPA / kainate receptor antagonist | 10mg | 1887.00 | 143692-48-2 |
| AB120490 | GYKI 53655 hydrochloride | Non-competitive AMPA / kainate receptor antagonist | 50mg | 8159.00 | 143692-48-2 |
| AB120491 | (S)-(-)-Blebbistatin | Selective myosin II ATPase activity inhibitor | 1mg | 888.00 | 856925-71-8 |
| AB120491 | (S)-(-)-Blebbistatin | Selective myosin II ATPase activity inhibitor | 5mg | 2886.00 | 856925-71-8 |
| AB120492 | CGP 7930 | Positive GABAB receptor allosteric modulator | 10mg | 1277.00 | 57717-80-3 |
| AB120492 | CGP 7930 | Positive GABAB receptor allosteric modulator | 50mg | 5106.00 | 57717-80-3 |
| AB120493 | Adenosine 3',5'-cyclic monophosphate (cAMP) | Second messenger. PKA activator. | 1g | 1887.00 | 60-92-4 |
| AB120493 | Adenosine 3',5'-cyclic monophosphate (cAMP) | Second messenger. PKA activator. | 5g | 6993.00 | 60-92-4 |
| AB120493 | Adenosine 3',5'-cyclic monophosphate (cAMP) | Second messenger. PKA activator. | 25g | 21312.00 | 60-92-4 |
| AB120494 | Nigericin Na+ salt | K+ ionophore | 10mg | 1499.00 | 28643-80-3 |
| AB120494 | Nigericin Na+ salt | K+ ionophore | 50mg | 5661.00 | 28643-80-3 |
| AB120495 | Anisomycin | Protein synthesis inhibitor | 10mg | 777.00 | 22862-76-6 |
| AB120495 | Anisomycin | Protein synthesis inhibitor | 50mg | 2997.00 | 22862-76-6 |
| AB120497 | Bafilomycin A1 | Highly potent, selective (V)-ATPase inhibitor | 10ug | 1110.00 | 88899-55-2 |
| AB120497 | Bafilomycin A1 | Highly potent, selective (V)-ATPase inhibitor | 100ug | 3386.00 | 88899-55-2 |
| AB120498 | Adenosine | Endogenous P1 receptor agonist | 1g | 278.00 | 58-61-7 |
| AB120498 | Adenosine | Endogenous P1 receptor agonist | 5g | 500.00 | 58-61-7 |
| AB120498 | Adenosine | Endogenous P1 receptor agonist | 25g | 777.00 | 58-61-7 |
| AB120499 | Monensin sodium salt | Na+ ionophore | 1g | 888.00 | 22373-78-0 |
| AB120499 | Monensin sodium salt | Na+ ionophore | 100mg | 278.00 | 22373-78-0 |
| AB120500 | Esomeprazole sodium | H+/ K+-ATPase (proton pump) inhibitor | 50mg | 500.00 | 161796-78-7 |
| AB120500 | Esomeprazole sodium | H+/ K+-ATPase (proton pump) inhibitor | 250mg | 2387.00 | 161796-78-7 |
| AB120501 | Leptomycin B (ethanol solution) | Antibiotic, antifungal. Inhibitor of CRM-1 mediated nuclear export. | 5ug | 2997.00 | 87081-35-4 |
| AB120501 | Leptomycin B (ethanol solution) | Antibiotic, antifungal. Inhibitor of CRM-1 mediated nuclear export. | 25ug | 8991.00 | 87081-35-4 |
| AB120502 | GW542573X | Novel, selective KCa2 channel activator | 10mg | 1610.00 | 660846-41-3 |
| AB120502 | GW542573X | Novel, selective KCa2 channel activator | 50mg | 7160.00 | 660846-41-3 |
| AB120503 | BAPTA-AM | Selective Ca2+ chelator. Analogue of BAPTA. | 25mg | 1277.00 | 126150-97-8 |
| AB120504 | Flecainide | Sodium channel blocker | 10mg | 500.00 | 54143-55-4 |
| AB120504 | Flecainide | Sodium channel blocker | 50mg | 1998.00 | 54143-55-4 |
| AB120505 | Simvastatin | HMG-CoA reductase inhibitor | 50mg | 1499.00 | 79902-63-9 |
| AB120505 | Simvastatin | HMG-CoA reductase inhibitor | 250mg | 5883.00 | 79902-63-9 |
| AB120506 | Cinnabarinic acid | Endogenous mGlu4 selective agonist | 10mg | 1499.00 | 606-59-7 |
| AB120506 | Cinnabarinic acid | Endogenous mGlu4 selective agonist | 50mg | 6383.00 | 606-59-7 |
| AB120507 | (R)-(+)-8-Hydroxy-DPAT hydrobromide (8-Hydroxy DPAT) | Selective full 5-HT1A receptor agonist | 10mg | 1499.00 | 78095-19-9 |
| AB120507 | (R)-(+)-8-Hydroxy-DPAT hydrobromide (8-Hydroxy DPAT) | Selective full 5-HT1A receptor agonist | 50mg | 6272.00 | 78095-19-9 |
| AB120511 | 1-Phenylbiguanide | 5HT3 receptor agonist | 1g | 1499.00 | 102-02-3 |
| AB120511 | 1-Phenylbiguanide | 5HT3 receptor agonist | 100mg | 500.00 | 102-02-3 |
| AB120514 | Sumatriptan succinate | 5-HT1 receptor agonist | 10mg | 777.00 | 103628-48-4 |
| AB120514 | Sumatriptan succinate | 5-HT1 receptor agonist | 50mg | 3386.00 | 103628-48-4 |
| AB120515 | L-694,247 | Highly potent 5-HT1D/5-HT1B receptor agonist | 10mg | 1776.00 | 137403-12-4 |
| AB120515 | L-694,247 | Highly potent 5-HT1D/5-HT1B receptor agonist | 50mg | 7493.00 | 137403-12-4 |
| AB120517 | BRL 15572 monohydrochloride | Selective 5-HT1D receptor antagonist | 10mg | 1499.00 | 1173022-77-9 |
| AB120517 | BRL 15572 monohydrochloride | Selective 5-HT1D receptor antagonist | 50mg | 5994.00 | 1173022-77-9 |
| AB120520 | BMY 7378 dihydrochloride | 5-HT1A partial agonist. alpha-adrenoceptor antagonist. | 10mg | 500.00 | 21102-95-4 |
| AB120520 | BMY 7378 dihydrochloride | 5-HT1A partial agonist. alpha-adrenoceptor antagonist. | 50mg | 1998.00 | 21102-95-4 |
| AB120521 | Pindolol | 5-HT1A and 5-HT1B receptor antagonist | 1g | 999.00 | 13523-86-9 |
| AB120521 | Pindolol | 5-HT1A and 5-HT1B receptor antagonist | 250mg | 611.00 | 13523-86-9 |
| AB120522 | CP 94253 dihydrochloride | Highly potent, selective 5-HT1B agonist | 10mg | 1610.00 | 131084-35-0 |
| AB120522 | CP 94253 dihydrochloride | Highly potent, selective 5-HT1B agonist | 50mg | 6660.00 | 131084-35-0 |
| AB120523 | GR 127935 hydrochloride | Potent, selective 5-HT1B/1D receptor antagonist | 10mg | 1998.00 | 148642-42-6 |
| AB120523 | GR 127935 hydrochloride | Potent, selective 5-HT1B/1D receptor antagonist | 50mg | 8658.00 | 148642-42-6 |
| AB120524 | LY 310762 hydrochloride | Potent, 5-HT1D antagonist | 10mg | 1499.00 | 192927-92-7 |
| AB120524 | LY 310762 hydrochloride | Potent, 5-HT1D antagonist | 50mg | 6383.00 | 192927-92-7 |
| AB120526 | Metergoline | Potent 5-HT receptor antagonist | 10mg | 500.00 | 17692-51-2 |
| AB120526 | Metergoline | Potent 5-HT receptor antagonist | 50mg | 2109.00 | 17692-51-2 |
| AB120528 | Serotonin hydrochloride (5-HT/5-Hydroxytryptamine) | Endogenous neurotransmitter, 5HT receptor agonist | 1g | 5495.00 | 153-98-0 |
| AB120528 | Serotonin hydrochloride (5-HT/5-Hydroxytryptamine) | Endogenous neurotransmitter, 5HT receptor agonist | 50mg | 500.00 | 153-98-0 |
| AB120528 | Serotonin hydrochloride (5-HT/5-Hydroxytryptamine) | Endogenous neurotransmitter, 5HT receptor agonist | 250mg | 1887.00 | 153-98-0 |
| AB120529 | Sibutramine hydrochloride | Serotonin, noradrenaline & dopamine re-uptake inhibitor | 10mg | 611.00 | 84485-00-7 |
| AB120529 | Sibutramine hydrochloride | Serotonin, noradrenaline & dopamine re-uptake inhibitor | 50mg | 1610.00 | 84485-00-7 |
| AB120530 | Methysergide maleate | 5-HT receptor antagonist | 10mg | 1776.00 | 129-49-7 |
| AB120530 | Methysergide maleate | 5-HT receptor antagonist | 50mg | 7770.00 | 129-49-7 |
| AB120531 | Nicardipine hydrochloride | L-type Ca2+ channel antagonist | 1g | 888.00 | 54527-84-3 |
| AB120531 | Nicardipine hydrochloride | L-type Ca2+ channel antagonist | 5g | 3275.00 | 54527-84-3 |
| AB120532 | L-cis-Diltiazem | Selective cyclic nucleotide-gated channel blocker | 5mg | 999.00 | 42399-54-2 |
| AB120532 | L-cis-Diltiazem | Selective cyclic nucleotide-gated channel blocker | 25mg | 4385.00 | 42399-54-2 |
| AB120534 | Bupropion hydrochloride | Non-selective DAT/NET inhibitor | 1g | 12765.00 | 31677-93-7 |
| AB120534 | Bupropion hydrochloride | Non-selective DAT/NET inhibitor | 50mg | 1110.00 | 31677-93-7 |
| AB120534 | Bupropion hydrochloride | Non-selective DAT/NET inhibitor | 250mg | 4107.00 | 31677-93-7 |
| AB120535 | Pancuronium dibromide | Competitive nicotinic acetylcholine receptor (nAChR) antagonist | 10mg | 500.00 | 15500-66-0 |
| AB120535 | Pancuronium dibromide | Competitive nicotinic acetylcholine receptor (nAChR) antagonist | 50mg | 1776.00 | 15500-66-0 |
| AB120535 | Pancuronium dibromide | Competitive nicotinic acetylcholine receptor (nAChR) antagonist | 250mg | 5994.00 | 15500-66-0 |
| AB120536 | Vecuronium bromide | Competitive nicotinic acetylcholine receptor (nAChR) antagonist | 10mg | 888.00 | 50700-72-6 |
| AB120536 | Vecuronium bromide | Competitive nicotinic acetylcholine receptor (nAChR) antagonist | 50mg | 1499.00 | 50700-72-6 |
| AB120536 | Vecuronium bromide | Competitive nicotinic acetylcholine receptor (nAChR) antagonist | 250mg | 5883.00 | 50700-72-6 |
| AB120537 | (-)-Cytisine | Potent, selective nAChR agonist | 10mg | 777.00 | 485-35-8 |
| AB120537 | (-)-Cytisine | Potent, selective nAChR agonist | 50mg | 2997.00 | 485-35-8 |
| AB120538 | Hexamethonium bromide | Antagonist at a3-containing nAChR | 1g | 2276.00 | 55-97-0 |
| AB120538 | Hexamethonium bromide | Antagonist at a3-containing nAChR | 100mg | 389.00 | 55-97-0 |
| AB120540 | Quipazine dimaleate | 5-HT receptor agonist | 50mg | 777.00 | 150323-78-7 |
| AB120540 | Quipazine dimaleate | 5-HT receptor agonist | 250mg | 2997.00 | 150323-78-7 |
| AB120542 | alpha-Bungarotoxin | Subtype-selective alpha7 nAChR antagonist | 1mg | 1499.00 | 11032-79-4 |
| AB120543 | NAN-190 hydrobromide | Potent 5-HT1A antagonist | 50mg | 888.00 | 115388-32-4 |
| AB120543 | NAN-190 hydrobromide | Potent 5-HT1A antagonist | 250mg | 3996.00 | 115388-32-4 |
| AB120544 | GR113808 | Potent, highly selective 5-HT4 antagonist | 10mg | 1277.00 | 144625-51-4 |
| AB120544 | GR113808 | Potent, highly selective 5-HT4 antagonist | 50mg | 5384.00 | 144625-51-4 |
| AB120546 | LY 272015 hydrochloride | Highly potent, selective 5-HT2B antagonist | 10mg | 1887.00 | 172895-15-7 |
| AB120546 | LY 272015 hydrochloride | Highly potent, selective 5-HT2B antagonist | 50mg | 8159.00 | 172895-15-7 |
| AB120548 | Cisapride | 5-HT4 receptor agonist. hERG blocker. | 10mg | 888.00 | 81098-60-4 |
| AB120548 | Cisapride | 5-HT4 receptor agonist. hERG blocker. | 50mg | 3774.00 | 81098-60-4 |
| AB120549 | Spiperone hydrochloride | 5-HT and D2-like receptor antagonist | 50mg | 611.00 | 2022-29-9 |
| AB120549 | Spiperone hydrochloride | 5-HT and D2-like receptor antagonist | 250mg | 1277.00 | 2022-29-9 |
| AB120550 | WAY-100635 maleate | Potent, selective, silent 5-HT1A receptor antagonist | 10mg | 1277.00 | 634908-75-1 |
| AB120550 | WAY-100635 maleate | Potent, selective, silent 5-HT1A receptor antagonist | 50mg | 4995.00 | 634908-75-1 |
| AB120552 | alpha-(Methylamino)isobutyric acid | Glutamine transport inhibitor | 1g | 3774.00 | 2566-34-9 |
| AB120552 | alpha-(Methylamino)isobutyric acid | Glutamine transport inhibitor | 250mg | 1277.00 | 2566-34-9 |
| AB120553 | S 24795 | Partial alpha7 nAChR agonist | 10mg | 1110.00 | 304679-75-2 |
| AB120553 | S 24795 | Partial alpha7 nAChR agonist | 50mg | 4884.00 | 304679-75-2 |
| AB120554 | HC-030031 | TRPA1 blocker, orally active | 10mg | 888.00 | 349085-38-7 |
| AB120554 | HC-030031 | TRPA1 blocker, orally active | 50mg | 3608.00 | 349085-38-7 |
| AB120555 | alpha-Methyl 5-hydroxytryptamine maleate | 5-HT2A/2C receptor agonist | 10mg | 777.00 | 304-52-9 |
| AB120555 | alpha-Methyl 5-hydroxytryptamine maleate | 5-HT2A/2C receptor agonist | 50mg | 2997.00 | 304-52-9 |
| AB120555 | alpha-Methyl 5-hydroxytryptamine maleate | 5-HT2A/2C receptor agonist | 100mg | 5661.00 | 304-52-9 |
| AB120556 | SB 206553 hydrochloride | Potent, selective 5-HT2B and 5-HT2C receptor agonist | 10mg | 1887.00 | 158942-04-2 |
| AB120556 | SB 206553 hydrochloride | Potent, selective 5-HT2B and 5-HT2C receptor agonist | 50mg | 9158.00 | 158942-04-2 |
| AB120557 | TC-2403 oxalate | Potent alpha4beta2 nAChR selective agonist | 10mg | 1110.00 | 252870-46-5 |
| AB120557 | TC-2403 oxalate | Potent alpha4beta2 nAChR selective agonist | 50mg | 4884.00 | 252870-46-5 |
| AB120558 | PNU 282987 | Selective a7 nAChR agonist | 10mg | 1388.00 | 123464-89-1 |
| AB120558 | PNU 282987 | Selective a7 nAChR agonist | 50mg | 4607.00 | 123464-89-1 |
| AB120559 | PNU 120596 | Positive allosteric modulator for the a7 nicotinic acetylcholine receptor | 10mg | 1499.00 | 501925-31-1 |
| AB120559 | PNU 120596 | Positive allosteric modulator for the a7 nicotinic acetylcholine receptor | 50mg | 6383.00 | 501925-31-1 |
| AB120560 | GTS-21 dihydrochloride (DMBX-A) | alpha7 nicotinic acetylcholine receptor agonist | 10mg | 999.00 | 156223-05-1 |
| AB120560 | GTS-21 dihydrochloride (DMBX-A) | alpha7 nicotinic acetylcholine receptor agonist | 50mg | 3774.00 | 156223-05-1 |
| AB120562 | (-)-Nicotine ditartrate | Potent nAChR agonist | 50mg | 500.00 | 65-31-6 |
| AB120563 | (S)-(-)-Raclopride | D2 receptor antagonist | 10mg | 777.00 | 84225-95-6 |
| AB120563 | (S)-(-)-Raclopride | D2 receptor antagonist | 50mg | 2997.00 | 84225-95-6 |
| AB120564 | Cabergoline | D2-like receptor agonist | 10mg | 1499.00 | 81409-90-7 |
| AB120564 | Cabergoline | D2-like receptor agonist | 50mg | 5994.00 | 81409-90-7 |
| AB120565 | Dopamine hydrochloride | Endogenous neurotransmitter | 1g | 389.00 | 62-31-7 |
| AB120565 | Dopamine hydrochloride | Endogenous neurotransmitter | 5g | 888.00 | 62-31-7 |
| AB120566 | Domperidone | Peripheral D2-like receptor antagonist | 50mg | 777.00 | 57808-66-9 |
| AB120566 | Domperidone | Peripheral D2-like receptor antagonist | 500mg | 4995.00 | 57808-66-9 |
| AB120567 | SB-277011-A dihydrochloride | Potent, highly selective D3 antagonist | 5mg | 1110.00 | 1226917-67-4 |
| AB120567 | SB-277011-A dihydrochloride | Potent, highly selective D3 antagonist | 25mg | 4385.00 | 1226917-67-4 |
| AB120568 | PD 168077 maleate | Potent, selective D4 agonist | 10mg | 1499.00 | 190383-31-4 |
| AB120568 | PD 168077 maleate | Potent, selective D4 agonist | 50mg | 5994.00 | 190383-31-4 |
| AB120569 | Pramipexole dihydrochloride | Dopamine D2-like receptor agonist. D3-preferring. | 10mg | 611.00 | 104632-25-9 |
| AB120569 | Pramipexole dihydrochloride | Dopamine D2-like receptor agonist. D3-preferring. | 50mg | 2498.00 | 104632-25-9 |
| AB120570 | U 99194 maleate (PNU 99194) | Potent, selective D3 antagonist | 10mg | 1277.00 | 234757-41-6 |
| AB120570 | U 99194 maleate (PNU 99194) | Potent, selective D3 antagonist | 50mg | 5106.00 | 234757-41-6 |
| AB120573 | L-DOPA | (ab120565) precursor | 5g | 500.00 | 59-92-7 |
| AB120573 | L-DOPA | (ab120565) precursor | 25g | 1499.00 | 59-92-7 |
| AB120573 | L-DOPA | (ab120565) precursor | 100g | 4995.00 | 59-92-7 |
| AB120574 | Bromocriptine mesylate | Potent, selective D2-like dopamine receptor agonist | 100mg | 1610.00 | 22260-51-1 |
| AB120574 | Bromocriptine mesylate | Potent, selective D2-like dopamine receptor agonist | 500mg | 3386.00 | 22260-51-1 |
| AB120575 | Ropinirole hydrochloride | Selective D2-like receptor agonist | 10mg | 611.00 | 91374-20-8 |
| AB120575 | Ropinirole hydrochloride | Selective D2-like receptor agonist | 50mg | 2775.00 | 91374-20-8 |
| AB120576 | Asenapine maleate | Multiple receptor antagonist. Anti-psychotic agent. | 10mg | 611.00 | 85650-56-2 |
| AB120576 | Asenapine maleate | Multiple receptor antagonist. Anti-psychotic agent. | 50mg | 2498.00 | 85650-56-2 |
| AB120578 | (R,S)-Sulpiride | D2-like dopamine receptor antagonist | 100mg | 500.00 | 15676-16-1 |
| AB120579 | (S)-Sulpiride | D2-like dopamine antagonist. Active enantiomer. | 1g | 1887.00 | 23672-07-3 |
| AB120579 | (S)-Sulpiride | D2-like dopamine antagonist. Active enantiomer. | 100mg | 611.00 | 23672-07-3 |
| AB120580 | Thioridazine hydrochloride | Dopamine receptor antagonist | 100mg | 611.00 | 130-61-0 |
| AB120580 | Thioridazine hydrochloride | Dopamine receptor antagonist | 500mg | 2276.00 | 130-61-0 |
| AB120581 | A-412997 dihydrochloride | Highly selective D4 agonist | 10mg | 1277.00 | 630116-49-3 |
| AB120581 | A-412997 dihydrochloride | Highly selective D4 agonist | 50mg | 4995.00 | 630116-49-3 |
| AB120583 | SB 216641 hydrochloride | Selective h5-HT1B antagonist | 10mg | 1887.00 | 193611-67-5 |
| AB120583 | SB 216641 hydrochloride | Selective h5-HT1B antagonist | 50mg | 8381.00 | 193611-67-5 |
| AB120585 | RS 127445 hydrochloride | Selective, potent 5-HT2B antagonist | 10mg | 1610.00 | 199864-86-3 |
| AB120585 | RS 127445 hydrochloride | Selective, potent 5-HT2B antagonist | 50mg | 7160.00 | 199864-86-3 |
| AB120586 | GR 46611 | 5-HT1B/1D agonist | 10mg | 1499.00 | 185259-85-2 |
| AB120586 | GR 46611 | 5-HT1B/1D agonist | 50mg | 6383.00 | 185259-85-2 |
| AB120587 | Nefazodone hydrochloride | Potent 5-HT2A antagonist | 10mg | 1110.00 | 82752-99-6 |
| AB120587 | Nefazodone hydrochloride | Potent 5-HT2A antagonist | 50mg | 3774.00 | 82752-99-6 |
| AB120589 | SB 271046 hydrochloride | Potent, selective 5-HT6 antagonist | 10mg | 1776.00 | 209481-24-3 |
| AB120589 | SB 271046 hydrochloride | Potent, selective 5-HT6 antagonist | 50mg | 7493.00 | 209481-24-3 |
| AB120590 | SB 699551 dihydrochloride | Selective 5-HT5A receptor antagonist | 10mg | 1887.00 | 791789-61-2 |
| AB120590 | SB 699551 dihydrochloride | Selective 5-HT5A receptor antagonist | 50mg | 8159.00 | 791789-61-2 |
| AB120591 | 5-Methyltryptamine hydrochloride | 5-HT agonist | 250mg | 500.00 | 1010-95-3 |
| AB120592 | LY 344864 hydrochloride | Selective, potent 5-HT1F agonist | 10mg | 1887.00 | 186544-26-3 |
| AB120592 | LY 344864 hydrochloride | Selective, potent 5-HT1F agonist | 50mg | 7992.00 | 186544-26-3 |
| AB120593 | LP-44 | Highly potent, selective 5-HT7 agonist | 10mg | 1887.00 | 824958-12-5 |
| AB120593 | LP-44 | Highly potent, selective 5-HT7 agonist | 50mg | 7992.00 | 824958-12-5 |
| AB120594 | LP-12 hydrochloride | 5-HT7 agonist | 10mg | 1776.00 | 1185136-22-4 |
| AB120594 | LP-12 hydrochloride | 5-HT7 agonist | 50mg | 7659.00 | 1185136-22-4 |
| AB120595 | SB 204741 | Selective 5-HT2B receptor antagonist | 10mg | 1388.00 | 152239-46-8 |
| AB120595 | SB 204741 | Selective 5-HT2B receptor antagonist | 50mg | 5495.00 | 152239-46-8 |
| AB120596 | L-741,626 | Potent and selective D2 antagonist | 10mg | 1110.00 | 81226-60-0 |
| AB120596 | L-741,626 | Potent and selective D2 antagonist | 50mg | 4884.00 | 81226-60-0 |
| AB120597 | SCH 23390 hydrochloride | Selective D1-like dopamine receptor antagonist | 10mg | 1388.00 | 125941-87-9 |
| AB120597 | SCH 23390 hydrochloride | Selective D1-like dopamine receptor antagonist | 50mg | 5384.00 | 125941-87-9 |
| AB120598 | L-745870 trihydrochloride | Highly potent, selective brain penetrant D4 antagonist | 10mg | 1277.00 | 866021-03-6 |
| AB120598 | L-745870 trihydrochloride | Highly potent, selective brain penetrant D4 antagonist | 50mg | 5106.00 | 866021-03-6 |
| AB120601 | Rotigotine hydrochloride | Dopamine receptor agonist | 10mg | 1110.00 | 125572-93-2 |
| AB120601 | Rotigotine hydrochloride | Dopamine receptor agonist | 50mg | 4496.00 | 125572-93-2 |
| AB120602 | Eticlopride hydrochloride | Selective D2-like receptor antagonist | 10mg | 1277.00 | 97612-24-3 |
| AB120602 | Eticlopride hydrochloride | Selective D2-like receptor antagonist | 50mg | 5384.00 | 97612-24-3 |
| AB120603 | Salsolinol hydrochloride | Endogenously synthesised dopamine derivative | 100mg | 611.00 | 70681-20-8 |
| AB120604 | (R)-(-)-Deprenyl hydrochloride (Selegiline hydrochloride) | MAO-B selective inhibitor | 1g | 1610.00 | 14611-52-0 |
| AB120604 | (R)-(-)-Deprenyl hydrochloride (Selegiline hydrochloride) | MAO-B selective inhibitor | 250mg | 611.00 | 14611-52-0 |
| AB120605 | Harmane | beta-Carboline. Imidazoline ligand. MAO inhibitor. | 100mg | 500.00 | 486-84-0 |
| AB120606 | Tranylcypromine hydrochloride (2-PCPA) | Irreversible monoamine oxidase (MAO) inhibitor | 50mg | 389.00 | 1986-47-6 |
| AB120607 | GBR 12909 dihydrochloride | Selective dopamine transport inhibitor | 10mg | 777.00 | 67469-78-7 |
| AB120607 | GBR 12909 dihydrochloride | Selective dopamine transport inhibitor | 50mg | 2997.00 | 67469-78-7 |
| AB120609 | Reserpine | Irreversible vesicular monoamine transporter (VMAT2) antagonist | 1g | 1110.00 | 50-55-5 |
| AB120609 | Reserpine | Irreversible vesicular monoamine transporter (VMAT2) antagonist | 250mg | 389.00 | 50-55-5 |
| AB120611 | PD 168568 dihydrochloride | Potent and selective D4 antagonist | 10mg | 1388.00 | 210688-56-5 |
| AB120611 | PD 168568 dihydrochloride | Potent and selective D4 antagonist | 50mg | 6161.00 | 210688-56-5 |
| AB120613 | Flupenthixol dihydrochloride | Non-selective dopamine receptor antagonist | 50mg | 389.00 | 2413-38-9 |
| AB120614 | Lovastatin (Mevinolin) | Potent HMG CoA reductase inhibitor | 10mg | 777.00 | 75330-75-5 |
| AB120614 | Lovastatin (Mevinolin) | Potent HMG CoA reductase inhibitor | 50mg | 3386.00 | 75330-75-5 |
| AB120615 | Apocynin | Selective NADPH-oxidase inhibitor | 1g | 611.00 | 498-02-2 |
| AB120616 | 2,3-Butanedione 2-monoxime (BDM) | Non-selective myosin ATPase inhibitor | 500mg | 389.00 | 57-71-6 |
| AB120617 | PP3 | Negative control for the Src kinase inhibitor PP2 | 10mg | 1887.00 | 5334-30-5 |
| AB120618 | Curcumin (Diferuloylmethane) | Flavonoid. Lipooxygenase inhibitor.? Anti-oxidant, anti-inflammatory agent. | 50mg | 500.00 | 458-37-7 |
| AB120618 | Curcumin (Diferuloylmethane) | Flavonoid. Lipooxygenase inhibitor.? Anti-oxidant, anti-inflammatory agent. | 250mg | 1887.00 | 458-37-7 |
| AB120619 | (R)-(+)-SKF38393 hydrochloride | Selective D1 partial agonist. Active enantiomer of (plusminus)-SKF-38393. | 5mg | 1776.00 | 81702-42-3 |
| AB120620 | Ketoconazole | Potent cytochrome P450 inhibitor. Anti-fungal agent. | 100mg | 999.00 | 65277-42-1 |
| AB120621 | Diclofenac Sodium | Potent cyclo-oxygenase inhibitor | 1g | 389.00 | 15307-79-6 |
| AB120622 | Ellagic acid | Selective, casein kinase 2 (CK2) inhibitor | 50mg | 611.00 | 476-66-4 |
| AB120629 | Doxorubicin hydrochloride | Topoisomerase II inhibitor. Antibiotic with cytotoxic actions. | 10mg | 1388.00 | 25316-40-9 |
| AB120629 | Doxorubicin hydrochloride | Topoisomerase II inhibitor. Antibiotic with cytotoxic actions. | 50mg | 5772.00 | 25316-40-9 |
| AB120631 | Acyclovir | Inhibits viral DNA polymerase. Antiherpetic agent | 50mg | 777.00 | 59277-89-3 |
| AB120631 | Acyclovir | Inhibits viral DNA polymerase. Antiherpetic agent | 100mg | 1388.00 | 59277-89-3 |
| AB120633 | DAPT | gamma-secretase inhibitor | 10mg | 1776.00 | 208255-80-5 |
| AB120633 | DAPT | gamma-secretase inhibitor | 50mg | 7493.00 | 208255-80-5 |
| AB120636 | Andrographolide | Potent anti-inflammatory agent | 100mg | 389.00 | 5508-58-7 |
| AB120637 | KU-55933 | Potent, selective, competitive ATM kinase inhibitor | 10mg | 1776.00 | 587871-26-9 |
| AB120638 | SB 202190 | Highly selective, potent, cell permeable p38 MAP kinase inhibitor | 10mg | 1610.00 | 152121-30-7 |
| AB120638 | SB 202190 | Highly selective, potent, cell permeable p38 MAP kinase inhibitor | 50mg | 6660.00 | 152121-30-7 |
| AB120639 | PD 0325901 | PD 0325901 | 10mg | 2276.00 | |
| AB120639 | PD 0325901 | PD 0325901 | 50mg | 9380.00 | |
| AB120642 | SQ 22536 | Non-competitive adenylyl cyclase inhibitor | 10mg | 1277.00 | 17318-31-9 |
| AB120642 | SQ 22536 | Non-competitive adenylyl cyclase inhibitor | 50mg | 5384.00 | 17318-31-9 |
| AB120643 | Tranilast | Anti-inflammatory agent | 10mg | 1110.00 | 53902-12-8 |
| AB120643 | Tranilast | Anti-inflammatory agent | 50mg | 4773.00 | 53902-12-8 |
| AB120644 | Withaferin A from Withania somnifera | Naturally occurring withanolide/steroidal lactone with anti-cancer properties | 1mg | 1166.00 | 5119-48-2 |
| AB120645 | Edaravone (MCI-186) | Free radical scavenger with neuroprotective effects | 50mg | 999.00 | 89-25-8 |
| AB120645 | Edaravone (MCI-186) | Free radical scavenger with neuroprotective effects | 250mg | 3497.00 | 89-25-8 |
| AB120647 | Honokiol | Anti-inflammatory and chemotherapeutic agent | 10mg | 1110.00 | 35354-74-6 |
| AB120647 | Honokiol | Anti-inflammatory and chemotherapeutic agent | 25mg | 2276.00 | 35354-74-6 |
| AB120648 | SB 328437 | Highly potent and selective CCR3 antagonist | 10mg | 1554.00 | 247580-43-4 |
| AB120648 | SB 328437 | Highly potent and selective CCR3 antagonist | 50mg | 7049.00 | 247580-43-4 |
| AB120649 | SC-560 | Highly selective COX-1 inhibitor | 100mg | 1443.00 | 188817-13-2 |
| AB120650 | Sulindac sulfide | Active metabolite of Sulindac. COX-1/ 2 inhibitor. | 5mg | 611.00 | 32004-67-4 |
| AB120650 | Sulindac sulfide | Active metabolite of Sulindac. COX-1/ 2 inhibitor. | 25mg | 2498.00 | 32004-67-4 |
| AB120651 | Fluvastatin, Sodium Salt | Competitive HMG-CoA reductase inhibitor | 50mg | 999.00 | 93957-55-2 |
| AB120653 | 2-Methoxyestradiol | Potent antitumor and antiangiogenic agent | 10mg | 888.00 | 362-07-2 |
| AB120653 | 2-Methoxyestradiol | Potent antitumor and antiangiogenic agent | 50mg | 2886.00 | 362-07-2 |
| AB120654 | Betulinic acid | Anticancer agent. TGR5 agonist. | 10mg | 611.00 | 472-15-1 |
| AB120654 | Betulinic acid | Anticancer agent. TGR5 agonist. | 50mg | 2498.00 | 472-15-1 |
| AB120656 | Tamoxifen citrate | Estrogen receptor antagonist and partial agonist | 1g | 2775.00 | 54965-24-1 |
| AB120656 | Tamoxifen citrate | Estrogen receptor antagonist and partial agonist | 100mg | 611.00 | 54965-24-1 |
| AB120657 | 17beta-Estradiol | Selective agonist of ER receptor | 1g | 1499.00 | 50-28-2 |
| AB120657 | 17beta-Estradiol | Selective agonist of ER receptor | 100mg | 611.00 | 50-28-2 |
| AB120659 | Tobramycin, free base | Ribosomal translation inhibitor | 100mg | 777.00 | 32986-56-4 |
| AB120659 | Tobramycin, free base | Ribosomal translation inhibitor | 500mg | 2886.00 | 32986-56-4 |
| AB120660 | Ribavirin | Anti-viral nucleoside | 10mg | 389.00 | 36791-04-5 |
| AB120660 | Ribavirin | Anti-viral nucleoside | 50mg | 1110.00 | 36791-04-5 |
| AB120661 | Minocycline hydrochloride | Antibiotic. Demonstrates multiple effects. | 50mg | 777.00 | 13614-98-7 |
| AB120662 | Luteolin | Antioxidant, anti-inflammatory, anti-cancer flavonoid | 10mg | 777.00 | 491-70-3 |
| AB120662 | Luteolin | Antioxidant, anti-inflammatory, anti-cancer flavonoid | 50mg | 2997.00 | 491-70-3 |
| AB120663 | Colchicine from Colchicum autumnale | Inhibitor of microtubule formation | 1g | 999.00 | 64-86-8 |
| AB120664 | Mycophenolic Acid | Immunosuppressant. Inosine monophosphate dehydrogenase inhibitor. | 100mg | 999.00 | 24280-93-1 |
| AB120665 | GANT58 | Downstream Hh signaling inhibitor | 10mg | 1499.00 | 64048-12-0 |
| AB120665 | GANT58 | Downstream Hh signaling inhibitor | 50mg | 6494.00 | 64048-12-0 |
| AB120666 | Cryptotanshinone | STAT3 inhibitor with diverse biological activities | 10mg | 1110.00 | 35825-57-1 |
| AB120666 | Cryptotanshinone | STAT3 inhibitor with diverse biological activities | 50mg | 4884.00 | 35825-57-1 |
| AB120668 | URB 597 | Potent and selective FAAH inhibitor | 5mg | 888.00 | 546141-08-6 |
| AB120668 | URB 597 | Potent and selective FAAH inhibitor | 25mg | 2886.00 | 546141-08-6 |
| AB120669 | BRL 52537 hydrochloride | Highly selective, potent kappa-opioid agonist | 10mg | 1110.00 | 112282-24-3 |
| AB120669 | BRL 52537 hydrochloride | Highly selective, potent kappa-opioid agonist | 50mg | 4496.00 | 112282-24-3 |
| AB120673 | DADLE | delta-opioid peptide agonist | 1mg | 278.00 | 63631-40-3 |
| AB120673 | DADLE | delta-opioid peptide agonist | 5mg | 777.00 | 63631-40-3 |
| AB120674 | DAMGO | Potent and selective me opioid receptor agonist | 1mg | 500.00 | 78123-71-4 |
| AB120674 | DAMGO | Potent and selective me opioid receptor agonist | 5mg | 1499.00 | 78123-71-4 |
| AB120675 | DPDPE | Potent, selective delta opioid receptor agonist | 1mg | 999.00 | 88373-73-3 |
| AB120675 | DPDPE | Potent, selective delta opioid receptor agonist | 5mg | 4107.00 | 88373-73-3 |
| AB120676 | Endomorphin 2 | Potent, selective me opioid receptor agonist | 5mg | 999.00 | 141801-26-5 |
| AB120680 | CTAP | Potent, selective me opioid antagonist | 1mg | 1277.00 | 103429-32-9 |
| AB120681 | Dynorphin B | Endogenous opioid peptide. kappa opioid agonist. | 1mg | 1887.00 | 83335-41-5 |
| AB120682 | Nociceptin (1-13) NH2 | Potent ORL1 agonist | 1mg | 888.00 | 178064-02-3 |
| AB120684 | SNC80 | Highly potent, selective delta opioid receptor agonist | 10mg | 1887.00 | 156727-74-1 |
| AB120684 | SNC80 | Highly potent, selective delta opioid receptor agonist | 50mg | 7770.00 | 156727-74-1 |
| 120685 | Pitstop 1? | Novel, selective clathrin inhibitor | 5mg | 1998.00 | |
| AB120686 | Pitstop 1? - negative control | Negative control for clathrin inhibitor Pitstop 1? | 5mg | 1998.00 | |
| AB120687 | Pitstop 2™ | Novel, selective cell permeable clathrin inhibitor | 5mg | 1998.00 | |
| AB120688 | Pitstop 2™ - negative control | Negative control for clathrin inhibitor Pitstop 2™ | 5mg | 1998.00 | |
| AB120689 | Dyngo-4a™ | Novel, highly potent dynamin inhibitor. Dynasore (ab120192) analogue. | 5mg | 1998.00 | |
| AB120708 | [DAla2]Deltorphin II | Selective delta opioid receptor agonist | 1mg | 777.00 | 122752-16-3 |
| AB120709 | Carvedilol | Potent beta and alpha1-adrenoceptor antagonist | 50mg | 611.00 | 72956-09-3 |
| AB120709 | Carvedilol | Potent beta and alpha1-adrenoceptor antagonist | 250mg | 2886.00 | 72956-09-3 |
| AB120710 | Isoprenaline hydrochloride | Non selective beta-adrenoceptor agonist | 100mg | 777.00 | 51-30-9 |
| AB120711 | Metoprolol tartrate | beta1-adrenergic receptor antagonist | 50mg | 611.00 | 56392-17-7 |
| AB120712 | Oxymetazoline hydrochloride | alpha1A and partial alpha2A adrenoceptor agonist. | 100mg | 500.00 | 2315-02-8 |
| AB120713 | Loperamide hydrochloride | Selective me opioid receptor agonist | 1g | 777.00 | 34552-83-5 |
| AB120714 | Salbutamol hemisulfate | Non-selective beta-adrenoceptor agonist | 50mg | 777.00 | 51022-70-9 |
| AB120714 | Salbutamol hemisulfate | Non-selective beta-adrenoceptor agonist | 250mg | 1110.00 | 51022-70-9 |
| AB120715 | Venlafaxine hydrochloride | Serotonin-noradrenaline reuptake inhibitor | 10mg | 944.00 | 99300-78-4 |
| AB120715 | Venlafaxine hydrochloride | Serotonin-noradrenaline reuptake inhibitor | 50mg | 3996.00 | 99300-78-4 |
| AB120716 | (-)-Epigallocatechin Gallate | Potent anti-oxidant flavonoid | 1mg | 888.00 | 989-51-5 |
| AB120717 | L-(-)-Norepinephrine-(+)-bitartrate (Noradrenaline) | Endogenous alpha adrenoceptor agonist | 1g | 1499.00 | 108341-18-0 |
| AB120717 | L-(-)-Norepinephrine-(+)-bitartrate (Noradrenaline) | Endogenous alpha adrenoceptor agonist | 5g | 6161.00 | 108341-18-0 |
| AB120718 | AMD3100 octahydrochloride | Highly selective CXCR4 antagonist | 10mg | 1277.00 | 155148-31-5 |
| AB120719 | Indomethacin | Non-selective COX inhibitor | 100mg | 777.00 | 53-86-1 |
| AB120720 | Triptolide from Tripterygium wilfordii | Anti-inflammatory agent with multiple biological activities | 1mg | 888.00 | 38748-32-2 |
| AB120720 | Triptolide from Tripterygium wilfordii | Anti-inflammatory agent with multiple biological activities | 10mg | 2276.00 | 38748-32-2 |
| AB120721 | Myricetin | Potent anti-neoplastic, anti-oxidant and anti-inflammatory agent | 5mg | 389.00 | 529-44-2 |
| AB120721 | Myricetin | Potent anti-neoplastic, anti-oxidant and anti-inflammatory agent | 25mg | 1110.00 | 529-44-2 |
| AB120722 | Piceatannol | Syk tyrosine kinase inhibitor | 10mg | 1499.00 | 10083-24-6 |
| AB120722 | Piceatannol | Syk tyrosine kinase inhibitor | 50mg | 4884.00 | 10083-24-6 |
| AB120723 | Baicalein | Flavonoid. Lipoxygenase inhibitor. | 50mg | 777.00 | 491-67-8 |
| AB120724 | Inosine | Purine nucleoside. Adenosine metabolite. | 1g | 389.00 | 58-63-9 |
| AB120724 | Inosine | Purine nucleoside. Adenosine metabolite. | 100mg | 278.00 | 58-63-9 |
| AB120725 | Pentoxifylline | Phosphodiesterase inhibitor. Cytokine inhibitor. | 1g | 278.00 | 6493-05-6 |
| AB120725 | Pentoxifylline | Phosphodiesterase inhibitor. Cytokine inhibitor. | 5g | 500.00 | 6493-05-6 |
| AB120726 | Resveratrol | Antioxidant polyphenol with a multitude of biological activities | 100mg | 888.00 | 501-36-0 |
| AB120726 | Resveratrol | Antioxidant polyphenol with a multitude of biological activities | 500mg | 2997.00 | 501-36-0 |
| AB120727 | Deferoxamine Mesylate | Iron chelator | 1g | 888.00 | 138-14-7 |
| AB120728 | trans-Retinoic Acid | Vitamin A metabolite. Stem cell differentiator. | 50mg | 389.00 | 302-79-4 |
| AB120728 | trans-Retinoic Acid | Vitamin A metabolite. Stem cell differentiator. | 500mg | 777.00 | 302-79-4 |
| AB120729 | (plusmn)-Chlorpheniramine maleate | Potent H1 antagonist and SNRI | 100mg | 389.00 | 113-92-8 |
| AB120730 | Chlorpromazine hydrochloride | Typical antipsychotic. Non-selective receptor antagonist. | 1g | 278.00 | 69-09-0 |
| AB120730 | Chlorpromazine hydrochloride | Typical antipsychotic. Non-selective receptor antagonist. | 5g | 777.00 | 69-09-0 |
| AB120731 | Cimetidine | Prototypic H2 antagonist. I1 agonist. | 100mg | 500.00 | 51481-61-9 |
| AB120732 | Cyproheptadine hydrochloride | Potent H1 and 5-HT2B antagonist. Non-selective receptor antagonist. | 50mg | 777.00 | 41354-29-4 |
| AB120732 | Cyproheptadine hydrochloride | Potent H1 and 5-HT2B antagonist. Non-selective receptor antagonist. | 100mg | 1277.00 | 41354-29-4 |
| AB120733 | Diphenhydramine hydrochloride | Potent H1 antagonist | 1g | 999.00 | 147-24-0 |
| AB120733 | Diphenhydramine hydrochloride | Potent H1 antagonist | 500mg | 611.00 | 147-24-0 |
| AB120734 | Histamine dihydrochloride | Endogenous histamine receptor agonist | 50mg | 500.00 | 56-92-8 |
| AB120734 | Histamine dihydrochloride | Endogenous histamine receptor agonist | 250mg | 1776.00 | 56-92-8 |
| AB120735 | Mepyramine maleate | Selective H1 inverse agonist | 100mg | 611.00 | 59-33-6 |
| AB120736 | Olanzapine | Non-selective 5-HT, dopamine, histamine and muscarinic antagonist. | 10mg | 611.00 | 132539-06-1 |
| AB120736 | Olanzapine | Non-selective 5-HT, dopamine, histamine and muscarinic antagonist. | 50mg | 2498.00 | 132539-06-1 |
| AB120737 | Quetiapine hemifumarate | D2 and 5-HT2 antagonist. Antipsychotic. | 10mg | 611.00 | 111974-72-2 |
| AB120737 | Quetiapine hemifumarate | D2 and 5-HT2 antagonist. Antipsychotic. | 50mg | 2387.00 | 111974-72-2 |
| AB120738 | Ranitidine hydrochloride | Selective H2 antagonist | 10mg | 278.00 | 66357-35-5 |
| AB120738 | Ranitidine hydrochloride | Selective H2 antagonist | 50mg | 555.00 | 66357-35-5 |
| AB120739 | Trifluoperazine dihydrochloride | Cell permeable calmodulin antagonist | 1g | 389.00 | 440-17-5 |
| AB120740 | (±)-SKF38393 hydrochloride | D1-like dopamine receptor agonist | 100mg | 1277.00 | 62717-42-4 |
| AB120741 | Nociceptin (1-7) (Orphanin FQ (1-7)) | Bioactive fragment of nociceptin. ORL1 (NOP) receptor agonist. | 1mg | 1887.00 | 178249-42-8 |
| AB120743 | Dexamethasone | Anti-inflammatory glucocorticoid | 100mg | 611.00 | 50-02-2 |
| AB120744 | Clotrimazole | Non-selective P450 cytochrome inhibitor | 50mg | 500.00 | 23593-75-1 |
| AB120745 | Valproic acid, sodium salt | Histone deacetylase inhibitor | 100mg | 500.00 | 1069-66-5 |
| AB120746 | Sodium salicylate | Cell permeable anti-inflammatory agent | 5g | 500.00 | 54-21-7 |
| AB120747 | Trolox | Antioxidant vitamin E derivative | 500mg | 555.00 | |
| AB120748 | Ouabain octahydrate | Na+/K+ ATPase inhibitor | 100mg | 611.00 | 11018-89-6 |
| AB120749 | Quinacrine dihydrochloride | Non-selective phospholipase A2 inhibitor | 100mg | 389.00 | 69-05-6 |
| AB120750 | L-Arginine | Precursor to nitric oxide synthesis | 100mg | 500.00 | 74-79-3 |
| AB120751 | Thioflavin T | Fluorescent cell permeable amyloid binding benzothiazol salt | 500mg | 555.00 | 2390-54-7 |
| AB120752 | (R,S)-Atenolol | beta1 adrenoceptor antagonist | 1g | 555.00 | 29122-68-7 |
| AB120753 | Clonidine hydrochloride | alpha2 adrenoreceptor agonist | 100mg | 611.00 | 4205-91-8 |
| AB120754 | Doxazosin mesylate | Selective alpha1-adrenoceptor antagonist | 50mg | 888.00 | 77883-43-3 |
| AB120755 | Milnacipran hydrochloride | Serotonin and noradrenalin reuptake inhibitor | 10mg | 888.00 | 101152-94-7 |
| AB120755 | Milnacipran hydrochloride | Serotonin and noradrenalin reuptake inhibitor | 50mg | 3497.00 | 101152-94-7 |
| AB120756 | Naftopidil hydrochloride | alpha1 adrenergic receptor antagonist | 10mg | 500.00 | 57149-07-2 |
| AB120756 | Naftopidil hydrochloride | alpha1 adrenergic receptor antagonist | 50mg | 1499.00 | 57149-07-2 |
| AB120757 | Propranolol hydrochloride | Potent beta-adrenoceptor antagonist | 100mg | 555.00 | 318-98-9 |
| AB120758 | (R)-Tomoxetine hydrochloride | Potent, selective norepinephrine re-uptake inhibitor | 10mg | 1388.00 | 82248-59-7 |
| AB120758 | (R)-Tomoxetine hydrochloride | Potent, selective norepinephrine re-uptake inhibitor | 50mg | 6161.00 | 82248-59-7 |
| AB120759 | Xylazine hydrochloride | alpha2 adrenergic receptor agonist | 1g | 500.00 | 23076-35-9 |
| AB120760 | Famotidine | Selective H2 antagonist | 1g | 999.00 | 76824-35-6 |
| AB120760 | Famotidine | Selective H2 antagonist | 500mg | 555.00 | 76824-35-6 |
| AB120761 | (R)-(-)-Phenylephrine hydrochloride | alpha1 adrenoceptor agonist | 100mg | 555.00 | 61-76-7 |
| AB120762 | Rosiglitazone | Selective PPARgamma agonist | 10mg | 555.00 | 122320-73-4 |
| AB120762 | Rosiglitazone | Selective PPARgamma agonist | 50mg | 2387.00 | 122320-73-4 |
| AB120763 | Donepezil hydrochloride | Acetylcholinesterase inhibitor | 10mg | 555.00 | 120011-70-3 |
| AB120763 | Donepezil hydrochloride | Acetylcholinesterase inhibitor | 50mg | 2109.00 | 120011-70-3 |
| AB120764 | Aripiprazole | Partial dopamine D2 agonist | 100mg | 1887.00 | 129722-12-9 |
| AB120764 | Aripiprazole | Partial dopamine D2 agonist | 500mg | 2276.00 | 129722-12-9 |
| AB120765 | Fexofenadine hydrochloride | Selective H1 receptor antagonist | 10mg | 944.00 | 153439-40-8 |
| AB120765 | Fexofenadine hydrochloride | Selective H1 receptor antagonist | 50mg | 3774.00 | 153439-40-8 |
| AB120766 | Loratidine | H1 receptor antagonist | 10mg | 1110.00 | 79794-75-5 |
| AB120766 | Loratidine | H1 receptor antagonist | 50mg | 4274.00 | 79794-75-5 |
| AB120767 | Dexmedetomidine hydrochloride | Potent, highly selective alpha2 agonist | 10mg | 1610.00 | 145108-58-3 |
| AB120767 | Dexmedetomidine hydrochloride | Potent, highly selective alpha2 agonist | 50mg | 6771.00 | 145108-58-3 |
| AB120768 | Dobutamine hydrochloride | beta1 and beta2 adrenoceptor agonist | 50mg | 1887.00 | 49745-95-1 |
| AB120769 | Maprotiline hydrochloride | Noradrenaline reuptake inhibitor | 100mg | 555.00 | 10347-81-6 |
| AB120770 | Octopamine hydrochloride | Full beta3 agonist: invertebrate biogenic amine | 100mg | 555.00 | 770-05-8 |
| AB120772 | Tamsulosin hydrochloride | Potent, selective alpha1A antagonist | 10mg | 2387.00 | 106463-17-6 |
| AB120772 | Tamsulosin hydrochloride | Potent, selective alpha1A antagonist | 50mg | 6771.00 | 106463-17-6 |
| AB120773 | UK 14,304 tartrate | Selective alpha2 adrenergic agonist | 10mg | 1277.00 | 59803-99-5 |
| AB120773 | UK 14,304 tartrate | Selective alpha2 adrenergic agonist | 50mg | 4829.00 | 59803-99-5 |
| AB120775 | CPPG | Potent group II/III metabotropic glutamate receptor antagonist | 10mg | 1499.00 | 183364-82-1 |
| AB120775 | CPPG | Potent group II/III metabotropic glutamate receptor antagonist | 50mg | 6993.00 | 183364-82-1 |
| AB120778 | Amthamine dihydrobromide | Selective H2 agonist | 10mg | 1277.00 | 106463-17-6 |
| AB120778 | Amthamine dihydrobromide | Selective H2 agonist | 50mg | 6050.00 | 106463-17-6 |
| AB120782 | Ketotifen fumarate | Selective, H1 antagonist | 100mg | 888.00 | 34580-14-8 |
| AB120783 | (plusminus)-Bisoprolol hemifumarate | Selective beta1 antagonist | 10mg | 1499.00 | 104344-23-2 |
| AB120783 | (plusminus)-Bisoprolol hemifumarate | Selective beta1 antagonist | 50mg | 6494.00 | 104344-23-2 |
| AB120784 | (S)-Timolol maleate | Potent non-selective beta-adrenoceptor antagonist | 100mg | 888.00 | 26921-17-5 |
| AB120785 | Atipamezole hydrochloride | Selective alpha2 adrenergic receptor antagonist | 10mg | 1610.00 | 104075-48-1 |
| AB120785 | Atipamezole hydrochloride | Selective alpha2 adrenergic receptor antagonist | 50mg | 6771.00 | 104075-48-1 |
| AB120786 | Formoterol hemifumarate | Potent long-acting beta2-adrenergic receptor antagonist | 10mg | 1332.00 | 43229-80-7 |
| AB120786 | Formoterol hemifumarate | Potent long-acting beta2-adrenergic receptor antagonist | 50mg | 5384.00 | 43229-80-7 |
| AB120787 | Medetomidine hydrochloride | Selective alpha2 adrenoceptor agonist | 10mg | 1166.00 | 86347-15-1 |
| AB120787 | Medetomidine hydrochloride | Selective alpha2 adrenoceptor agonist | 50mg | 4829.00 | 86347-15-1 |
| AB120788 | Mianserin hydrochloride | Multiple receptor antagonist. Activity at 5-HT2, H1 and alpha2 receptors. | 50mg | 777.00 | 21535-47-7 |
| AB120789 | Moxonidine hydrochloride | I1 imidazoline receptor and alpha2 adrenergic agonist | 10mg | 1332.00 | 75536-04-8 |
| AB120789 | Moxonidine hydrochloride | I1 imidazoline receptor and alpha2 adrenergic agonist | 50mg | 5384.00 | 75536-04-8 |
| AB120790 | Nebivolol hydrochloride | Selective beta1 antagonist | 10mg | 1554.00 | 152520-56-4 |
| AB120790 | Nebivolol hydrochloride | Selective beta1 antagonist | 50mg | 6993.00 | 152520-56-4 |
| AB120793 | TMPyP4 tosylate | Telomerase inhibitor. Binds and stabilizes DNA G-quadruplexes. | 50mg | 888.00 | 36951-72-1 |
| AB120794 | Pioglitazone hydrochloride | Selective PPAR-gamma agonist | 10mg | 611.00 | 112529-15-4 |
| AB120794 | Pioglitazone hydrochloride | Selective PPAR-gamma agonist | 50mg | 2276.00 | 112529-15-4 |
| AB120795 | Rhodadyn C10™ | Highly potent cell permeable dynamin I inhibitor | 5mg | 1998.00 | |
| AB120796 | Rhodadyn B10™ | Negative control for Rhodadyn C10™ | 5mg | 1998.00 | |
| AB120797 | Mitomycin C (MMC) | Anti-cancer and antibiotic agent | 2mg | 278.00 | 50-07-7 |
| AB120797 | Mitomycin C (MMC) | Anti-cancer and antibiotic agent | 10mg | 1277.00 | 50-07-7 |
| AB120800 | 2-Furoyl-LIGRLO-amide (2Fly) | Potent and selective PAR2 agonist | 1mg | 1110.00 | 729589-58-6 |
| AB120801 | TRAP-6 | PAR1 agonist | 5mg | 1887.00 | 141136-83-6 |
| AB120802 | SC-66 | Allosteric Akt inhibitor | 10mg | 888.00 | 871361-88-5 |
| AB120802 | SC-66 | Allosteric Akt inhibitor | 50mg | 3608.00 | 871361-88-5 |
| AB120803 | VU 0360223 | Potent mGlu5 antagonist | 10mg | 1610.00 | 1274859-33-4 |
| AB120803 | VU 0360223 | Potent mGlu5 antagonist | 50mg | 6771.00 | 1274859-33-4 |
| AB120804 | Calpeptin | Potent, cell permeable calpain inhibitor | 10mg | 1332.00 | 117591-20-5 |
| AB120804 | Calpeptin | Potent, cell permeable calpain inhibitor | 50mg | 6050.00 | 117591-20-5 |
| AB120810 | DAPTA | Potent, selective CCR5 antagonist | 1mg | 944.00 | 106362-34-9 |
| AB120811 | BX 513 hydrochloride | Potent and selective CCR1 antagonist | 10mg | 1887.00 | 1216540-18-9 |
| AB120811 | BX 513 hydrochloride | Potent and selective CCR1 antagonist | 50mg | 7992.00 | 1216540-18-9 |
| AB120814 | ZK 756326 | Non-peptide CCR8 chemokine receptor agonist | 10mg | 1388.00 | 874911-96-3 |
| AB120814 | ZK 756326 | Non-peptide CCR8 chemokine receptor agonist | 50mg | 6050.00 | 874911-96-3 |
| AB120815 | Jervine | Smoothened inhibitor | 1mg | 1277.00 | 469-59-0 |
| AB120815 | Jervine | Smoothened inhibitor | 5mg | 4496.00 | 469-59-0 |
| AB120816 | Itraconazole | Cytochrome p450 inhibitor | 50mg | 777.00 | 84625-61-6 |
| AB120816 | Itraconazole | Cytochrome p450 inhibitor | 100mg | 1277.00 | 84625-61-6 |
| AB120817 | [Gln11]-Amyloid beta Peptide (1-28) | Homologous to Amyloid beta protein. Induces amnesia. | 1mg | 1832.00 | 106686-61-7 |
| AB120817 | [Gln11]-Amyloid beta Peptide (1-28) | Homologous to Amyloid beta protein. Induces amnesia. | 500ug | 1110.00 | 106686-61-7 |
| AB120818 | LY 341495 disodium salt | Water-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 (ab120199) | 1mg | 999.00 | 106686-61-7 |
| AB120818 | LY 341495 disodium salt | Water-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 (ab120199) | 10mg | 2498.00 | 106686-61-7 |
| AB120818 | LY 341495 disodium salt | Water-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 (ab120199) | 50mg | 11045.00 | 106686-61-7 |
| AB120819 | JK 184 | Potent Hedgehog signaling inhibitor | 10mg | 1554.00 | 315703-52-7 |
| AB120819 | JK 184 | Potent Hedgehog signaling inhibitor | 50mg | 7049.00 | 315703-52-7 |
| AB120820 | [Gln22]-Amyloid beta Peptide (1-40) | Mutant amyloid beta (1-40) peptide | 1mg | 3441.00 | 144410-00-4 |
| AB120820 | [Gln22]-Amyloid beta Peptide (1-40) | Mutant amyloid beta (1-40) peptide | 500ug | 2331.00 | 144410-00-4 |
| AB120821 | SB 297006 | Potent, selective CCR3 antagonist | 10mg | 1610.00 | 58816-69-6 |
| AB120821 | SB 297006 | Potent, selective CCR3 antagonist | 50mg | 6771.00 | 58816-69-6 |
| AB120825 | Amyloid beta peptide (16-22) | Amyloidogenic peptide forming an antiparallel beta-sheet | 1mg | 1998.00 | |
| AB120826 | GSK 4716 | Selective ERRbetagamma agonist | 10mg | 888.00 | 101574-65-6 |
| AB120826 | GSK 4716 | Selective ERRbetagamma agonist | 50mg | 3552.00 | 101574-65-6 |
| AB120827 | Hydroxychloroquine sulfate | Anti-inflammatory and anti-malarial agent. | 5mg | 888.00 | 747-36-4 |
| AB120827 | Hydroxychloroquine sulfate | Anti-inflammatory and anti-malarial agent. | 25mg | 3386.00 | 747-36-4 |
| AB120829 | CyPPA | First selective SK channel activator | 10mg | 1554.00 | 73029-73-9 |
| AB120829 | CyPPA | First selective SK channel activator | 50mg | 7049.00 | 73029-73-9 |
| AB120830 | Amyloid beta Peptide (10-20) | Soluble amyloid beta peptide fragment | 1mg | 999.00 | 152286-31-2 |
| AB120831 | Telmisartan | Selective angiotensin II (AT1) antagonist | 10mg | 1388.00 | 144701-48-4 |
| AB120831 | Telmisartan | Selective angiotensin II (AT1) antagonist | 50mg | 5384.00 | 144701-48-4 |
| AB120832 | Fenofibrate | Potent, selective PPAR-alpha agonist | 5g | 389.00 | 49562-28-9 |
| AB120833 | Clofibric acid | PPARalpha agonist | 1g | 611.00 | 882-09-7 |
| AB120834 | Amyloid beta Peptide (1-11) | Amyloidogenic peptide | 1mg | 1832.00 | 190436-05-6 |
| AB120835 | TCS JNK 5a | Selective JNK2/3 inhibitor | 10mg | 1443.00 | 312917-14-9 |
| AB120835 | TCS JNK 5a | Selective JNK2/3 inhibitor | 50mg | 6494.00 | 312917-14-9 |
| AB120838 | Amyloid beta Peptide (12-28) | Toxic amyloid beta peptide fragment | 1mg | 1443.00 | 107015-83-8 |
| AB120838 | Amyloid beta Peptide (12-28) | Toxic amyloid beta peptide fragment | 500ug | 888.00 | 107015-83-8 |
| AB120842 | 5-Aza-2'-deoxycytidine | Potent DNA methyltransferase inhibitor; epigenetic modifier | 10mg | 1388.00 | 2353-33-5 |
| AB120842 | 5-Aza-2'-deoxycytidine | Potent DNA methyltransferase inhibitor; epigenetic modifier | 50mg | 5384.00 | 2353-33-5 |
| AB120846 | Amyloid beta Peptide (1-28) | Amyloidogenic peptide | 1mg | 3441.00 | 109770-29-8 |
| AB120846 | Amyloid beta Peptide (1-28) | Amyloidogenic peptide | 500ug | 2331.00 | 109770-29-8 |
| AB120847 | Metformin hydrochloride | AMPK activator | 100mg | 611.00 | 1115-70-4 |
| AB120851 | Amyloid beta Peptide (1-38) (Abeta38) | Toxic amyloid beta peptide fragment | 100ug | 2331.00 | 131438-74-9 |
| AB120852 | Valinomycin from Streptomyces fulvissimus | K+ selective ionophore | 10mg | 555.00 | 2001-95-8 |
| AB120852 | Valinomycin from Streptomyces fulvissimus | K+ selective ionophore | 50mg | 1887.00 | 2001-95-8 |
| AB120853 | Lithium chloride | GSK-3beta inhibitor | 1g | 333.00 | 7447-41-8 |
| AB120853 | Lithium chloride | GSK-3beta inhibitor | 5g | 611.00 | 7447-41-8 |
| AB120860 | (+)-Abscisic acid | Phytohormone; produced by a variety of cells in humans and animals | 1mg | 3885.00 | 21293-29-8 |
| AB120862 | Caffeic acid | Specific NF-kappaB inhibitor | 1g | 500.00 | 331-39-5 |
| AB120862 | Caffeic acid | Specific NF-kappaB inhibitor | 250mg | 278.00 | 331-39-5 |
| AB120863 | Hydralazine hydrochloride | DNA methylation inhibitor. Anti-hypertensive agent | 1g | 389.00 | 304-20-1 |
| AB120865 | Procaine hydrochloride | Na+ channel blocker. DNA methylation inhibitor. | 250mg | 555.00 | 51-05-8 |
| AB120866 | FFN102 (Mini 102) | Exogenous fluorescent substrate | 5mg | 1998.00 | 1234064-11-9 |
| AB120867 | FFN202 (Mini 202) | Novel, pH responsive FFN. Enables pH measurement of synaptic or secretory vesicles. | 5mg | 1998.00 | 1234064-29-9 |
| AB120870 | beta-Alanine | Endogenous glycine agonist | 1g | 500.00 | 107-95-9 |
| AB120873 | Fura-2 AM (Fura-2 acetoxymethyl ester) | Selective Ca2+ chelator; fluorescent indicator | 1mg | 1887.00 | 108964-32-5 |
| AB120948 | Sodium butyrate | Histone deacetylase inhibitor | 1g | 1554.00 | 156-54-7 |
| AB120948 | Sodium butyrate | Histone deacetylase inhibitor | 50mg | 389.00 | 156-54-7 |
| AB120948 | Sodium butyrate | Histone deacetylase inhibitor | 250mg | 611.00 | 156-54-7 |
| AB120951 | Nifuroxazide | JAK/STAT signaling inhibitor. Nitrofuran antibiotic. | 100mg | 333.00 | 965-52-6 |
| AB120952 | Stattic | Selective STAT3 inhibitor | 10mg | 777.00 | 19983-44-9 |
| AB120952 | Stattic | Selective STAT3 inhibitor | 50mg | 2886.00 | 19983-44-9 |
| AB120955 | Procainamide hydrochloride | Sodium channel blocker. Specific DNA methyltransferase inhibitor 1. | 10g | 389.00 | 614-39-1 |
| AB120955 | Procainamide hydrochloride | Sodium channel blocker. Specific DNA methyltransferase inhibitor 1. | 25g | 888.00 | 614-39-1 |
| AB120957 | Amyloid beta Peptide (1-40), (rat/mouse) | Rat form of the amyloid beta (1-40) peptide | 1mg | 2553.00 | 144409-98-3 |
| AB120959 | Amyloid beta Peptide (1-42) (rat/mouse) | Rat form of the amyloid beta (1-42) peptide | 500ug | 2553.00 | 166090-74-0 |
| AB120961 | Pterostilbene | Antioxidant and anti-apoptotic agent; analog of resveratrol | 10mg | 1943.00 | 537-42-8 |
| AB120963 | Amyloid beta Peptide (1-43) (Abeta43) | Highly toxic, amyloidogenic amyloid beta peptide fragment | 500ug | 4107.00 | 134500-80-4 |
| AB120964 | Crosstide | Akt peptide substrate | 1mg | 999.00 | 171783-05-4 |
| AB120965 | Crosstide (biotinylated) | Akt peptide substrate, biotinylated | 1mg | 1499.00 | |
| AB120967 | Cantharidin | Protein phosphatases 1 and 2A (PP1, PP2A) inhibitor | 25mg | 555.00 | 56-25-7 |
| AB120967 | Cantharidin | Protein phosphatases 1 and 2A (PP1, PP2A) inhibitor | 100mg | 1610.00 | 56-25-7 |
| AB120969 | Amyloid beta Peptide (22-35) | Cytotoxic amyloid beta peptide fragment | 1mg | 2775.00 | 144189-71-9 |
| AB120974 | Amyloid beta Peptide (31-35) | Amyloidogenic peptide | 1mg | 1499.00 | 149385-65-9 |
| AB120975 | Meropenem trihydrate | Broad-spectum beta-lactam antibiotic | 10mg | 500.00 | 119478-56-7 |
| AB120975 | Meropenem trihydrate | Broad-spectum beta-lactam antibiotic | 50mg | 2109.00 | 119478-56-7 |
| AB120977 | Amyloid beta Peptide (35-25) | Inactive control for Amyloid beta (25-35) | 1mg | 3330.00 | 147740-73-6 |
| AB120979 | Ro 67-4853 | PAM for mGlu1 | 10mg | 1110.00 | 302841-89-0 |
| AB120979 | Ro 67-4853 | PAM for mGlu1 | 50mg | 4884.00 | 302841-89-0 |
| AB120986 | Cardamonin | Anti-cancer, anti-inflammatory spice-derived chalcone analog | 10mg | 1443.00 | 19309-14-9 |
| AB120986 | Cardamonin | Anti-cancer, anti-inflammatory spice-derived chalcone analog | 50mg | 6438.00 | 19309-14-9 |
| AB120990 | Acetaminophen | Selective COX-3 inhibitor | 100mg | 888.00 | 103-90-2 |
| AB120992 | Amyloid beta Peptide (40-1) | Inactive control for Amyloid beta (1-40) (ab120479) peptide | 500ug | 4940.00 | 144409-99-4 |
| 上海博升生物科技有限公司 电 话： 021-5425 3791, 6469 3763 传 真： 021-6428 0007 咨询订购E-mail：order@biosun.cn 技术支持E-mail：tech@biosun.cn 网 址：www.biosun.cn 地 址：上海市徐汇区肇嘉浜路825号尚秀商务楼1号楼5楼 |